204 results on '"G. Manzoni"'
Search Results
2. Semi-closed-circuit vacuum-assisted mini-PCNL in the pediatric population: the initial experience by two tertiary referral centers
- Author
-
G. Sampogna, A. Gallioli, A. Berrettini, E. Llorens, Y. Quiróz, M. Gnech, E. De Lorenzis, G. Albo, J. Palou, G. Manzoni, A. Bujons, and E. Montanari
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
3. First Italian report on transitional care for highly complex urological diseases from pediatric to adult
- Author
-
G. Cretì, G. Mosiello, G. Manzoni, M. Soligo, A. Giammò, M. De Gennaro, G. Carrieri, A. Cretì, and A. Cisternino
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
4. Surgical and medical management of stone disease in children under 2 years
- Author
-
M. Gnech, F. Taroni, E.A. De Marco, M.C. Mancuso, D. Minoli, V. Capone, G. Montini, E. Montanari, G. Manzoni, and A. Berrettini
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
5. Mini-PCNL with a semi-closed-circuit vacuum-assisted system in pediatric patients treated by two European tertiary referral centers
- Author
-
G. Sampogna, A. Gallioli, A. Berrettini, S.P. Zanetti, E. Llorens, Y. Quiróz, M. Gnech, E.A. De Marco, D.G. Minoli, F. Taroni, E. De Lorenzis, G. Montini, G. Manzoni, A. Bujons Tur, and E. Montanari
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Published
- 2020
- Full Text
- View/download PDF
6. Is dorsal inlay graft urethroplasty safe and effective for revisional hypospadias repair in the pediatric age?
- Author
-
C. Bebi, M. Gnech, M.C. Clementi, D.G. Minoli, E.A. De Marco, F. Molinari, I. Paraboschi, A. Berrettini, and G. Manzoni
- Subjects
Urology - Published
- 2023
- Full Text
- View/download PDF
7. PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER, RANDOMIZED CONTROLLED STUDY ON FEASIBILITY, SAFETY AND EFFICACY OF THREE DIFFERENT TECHNIQUES OF ENDOSCOPIC GASTROPLASTY
- Author
-
S.F. Vadalà di Prampero, S. Masia, P. Bazzu, V. Cosseddu, F. Di Maio, G. Manzoni, C. Rocchi, M. Massidda, V. Milano, D. Pagliara, A. Bua, G. Delogu, P. Rinaldi, P. Giustacchini, and M. Bulajic
- Published
- 2022
- Full Text
- View/download PDF
8. Surgical outcomes and radiation exposure after antegrade sclerotherapy in the paediatric population: a single center experience
- Author
-
C. Bebi, M. Bilato, M. Gnech, E.A. De Marco, D.G. Minoli, I. Paraboschi, E. Montanari, L. Boeri, I. Fulgheri, G. Manzoni, and A. Berrettini
- Subjects
Urology - Published
- 2022
- Full Text
- View/download PDF
9. OC.16.3 THREE DIFFERENT TECHNIQUES OF ENDOSCOPIC GASTROPLASTY: TECHNICAL ASPECTS FROM PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER, RANDOMIZED CONTROLLED STUDY
- Author
-
S.F. Vadalà Di Prampero, S. Masia, P. Bazzu, V. Cosseddu, F. Di Maio, G. Manzoni, C. Rocchi, M. Massidda, V. Milano, D. Pagliara, A. Bua, G. Delogu, P. Rinaldi, P. Giustacchini, and M. Bulajic
- Subjects
Hepatology ,Gastroenterology - Published
- 2022
- Full Text
- View/download PDF
10. Lipotoxicity-associated inflammation is prevented by guarana (Paullinia cupana) in a model of hyperlipidemia
- Author
-
Josiane B.S. Braun, Juliana Sorraila de Oliveira, Daniela B.R. Leal, Cinthia Melazzo de Andrade, Lívia G. Castilhos, Daniela F. Passos, Fátima Husein Abdalla, Emerson André Casali, Jader B. Ruchel, Viviane M. Bernardes, Ivana Beatrice Mânica da Cruz, and Alessandra G. Manzoni
- Subjects
Health, Toxicology and Mutagenesis ,Inflammatory response ,Inflammation ,010501 environmental sciences ,Pharmacology ,Toxicology ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,food ,Hyperlipidemia ,medicine ,Paullinia cupana ,0105 earth and related environmental sciences ,Chemical Health and Safety ,business.industry ,Public Health, Environmental and Occupational Health ,General Medicine ,medicine.disease ,food.food ,chemistry ,Lipotoxicity ,Simvastatin ,medicine.symptom ,business ,Caffeine ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Hyperlipidemia causes lipotoxicity which prompts an inflammatory response linked to the development of cardiovascular diseases. Natural compounds have been receiving special attention for its poten...
- Published
- 2019
- Full Text
- View/download PDF
11. Tucumã ( Astrocaryum aculeatum ) prevents memory loss and oxidative imbalance in the brain of rats with hyperlipidemia
- Author
-
Fernanda Licker Cabral, Alessandra G. Manzoni, Matheus H Jantsch, Maria Rosa Chitolina Schetinger, Jean L.G. da Silva, Daniela B.R. Leal, Viviane M. Bernardes, Daniela F. Passos, Guilherme Lopes Dornelles, and Juliana Sorraila de Oliveira
- Subjects
Antioxidant ,Astrocaryum aculeatum ,030309 nutrition & dietetics ,medicine.medical_treatment ,Population ,Biophysics ,Hyperlipidemias ,Inflammation ,Pharmacology ,Neuroprotection ,03 medical and health sciences ,0404 agricultural biotechnology ,Nutraceutical ,Hyperlipidemia ,medicine ,Animals ,Rats, Wistar ,education ,Memory Disorders ,0303 health sciences ,education.field_of_study ,biology ,business.industry ,Brain ,04 agricultural and veterinary sciences ,Cell Biology ,medicine.disease ,biology.organism_classification ,040401 food science ,Rats ,Oxidative Stress ,Sample collection ,medicine.symptom ,business ,Oxidation-Reduction ,Food Science - Abstract
Hyperlipidemia generates deposition of lipids, inflammation, and oxidative damage in cells and tissues, including those of the brain. Tucumã (Astrocaryum aculeatum) fruits contain bioactive compounds with antioxidant and anti-inflammatory effects. We evaluated the action of Tucumã extract on memory and brain cortex redox balance in hyperlipidemic rats. For 30 days, Wistar rats received Tucumã extract (250 mg/kg). Then, hyperlipidemia was induced by intraperitoneal administration of Poloxamer-407. Twenty-four hours later, the object recognition index was measured. The animals were euthanized for sample collection 36 hr postinduction. Hyperlipidemic animals showed memory loss and an imbalance between reactive species and intrinsic antioxidants. We found that Tucumã prevented memory loss and protein and lipid oxidative damage and prompted a better antioxidant response in the cerebral cortex of rats with hyperlipidemia. These findings suggest a neuroprotective effect and nutraceutical potential of Tucumã. PRACTICAL APPLICATIONS: In the present work, we demonstrated that induced hyperlipidemia in rats caused memory loss and redox unbalance, both factors prevented by the administration of Tucumã (Astrocaryum aculeatum) extract. Two aims were fulfilled with these results. The first was to show that hyperlipidemia affected brain function through oxidative damage and concerned basic research. The second was to offer a therapy that prevented this harm and could be applied in the clinic. Tucumã has ethnopharmacological importance through the consumption of fruits or the administration of extracts and oils by a population that was shown to enjoy improved health and longevity. Here, we show evidence that Tucumã contributes to the maintenance of brain health by preventing memory loss and oxidative damage, a nutraceutical supplement that may aid the prevention of vascular, inflammatory, and brain diseases.
- Published
- 2021
- Full Text
- View/download PDF
12. Purine Metabolism in Platelets and Heart Cells of Hyperlipidemic Rats
- Author
-
Daniela F. Passos, Vânia Lúcia Loro, Daniela B.R. Leal, Alessandra G. Manzoni, Jossiele Leitemperger, and Pedro H. Doleski
- Subjects
0301 basic medicine ,Adenosine monophosphate ,Blood Platelets ,Male ,medicine.medical_specialty ,Curcumin ,Rutin ,Inflammation ,Hyperlipidemias ,Poloxamer ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Antioxidants ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Hyperlipidemia ,medicine ,Animals ,Pharmacology (medical) ,Myocytes, Cardiac ,Lymphocytes ,Rats, Wistar ,Pharmacology ,business.industry ,Hydrolysis ,General Medicine ,Metabolism ,medicine.disease ,Adenosine ,Eosinophils ,Adenosine diphosphate ,Disease Models, Animal ,Oxidative Stress ,030104 developmental biology ,Endocrinology ,chemistry ,Purines ,Lipid Peroxidation ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Adenosine triphosphate ,Oxidative stress ,medicine.drug - Abstract
Hyperlipidemia, characterized by an increase in circulating lipid levels, doubles the chance of developing cardiovascular diseases. It prompts inflammation, immune activation, and oxidative stress in the bloodstream and organs of rats. Thus, we theorized that the metabolism of purines, an immunomodulatory mechanism, is altered in cells involved in the development of cardiovascular diseases.Therefore, we induced acute hyperlipidemia in Wistar rats with Poloxamer-407 and euthanized the animals 36 h later. The leucocyte differential, the rate of purine metabolism on the surface of platelets and heart cells, and markers of oxidative stress in the heart tissue were evaluated. These parameters were also assessed in animals pretreated for 30 days with curcumin and/or rutin.Hyperlipidemia increased the hydrolyses of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) in platelets. In heart cells, the metabolism of ATP and adenosine (ADO) were increased, while ADP hydrolysis was reduced. Additionally, lipid damage and antioxidant defenses were increased in heart homogenates. Hyperlipidemic rats also exhibited a reduced percentage of eosinophils and lymphocytes.Together, these findings are indicative of an increased risk of developing cardiovascular diseases in hyperlipidemic rats. The pretreatments with antioxidants reverted some of the changes prompted by hyperlipidemia preventing detrimental changes in the cells and tissues. Graphical Abstract.
- Published
- 2020
13. La preghiera nei testi letterari della Grecia antica
- Author
-
Maria Pia Pattoni, G. Manzoni, Pattoni, Maria Pia, Maria Pia Pattoni (ORCID:0000-0001-9132-2010), Maria Pia Pattoni, G. Manzoni, Pattoni, Maria Pia, and Maria Pia Pattoni (ORCID:0000-0001-9132-2010)
- Abstract
Analisi delle tipologia di preghiera all'interno dei testi letterari della Grecia antica, da Omero alla tragedia attica di V secolo.
- Published
- 2021
14. Le guerre persiane nella tragedia attica di V secolo: i Persiani di Eschilo e il precedente di Frinico
- Author
-
Maria Pia Pattoni, G. Manzoni, Pattoni, Maria Pia, Maria Pia Pattoni (ORCID:0000-0001-9132-2010), Maria Pia Pattoni, G. Manzoni, Pattoni, Maria Pia, and Maria Pia Pattoni (ORCID:0000-0001-9132-2010)
- Abstract
I Persiani di Eschilo sono l’unico dramma conservato che prenda a soggetto non il mito bensì eventi storici recenti: il fallimento dell’invasione della Grecia ad opera del re persiano Serse nel 480/479 a.C. Dopo avere esaminato il contesto storico della rappresentazione, il saggio si sofferma in un’analisi commentata del dramma, anche in rapporto ai due precedenti drammi di Frinico, La presa di Mileto e i Persiani, anch’essi dedicati allo scontro tra la Grecia e l’impero persiano., The Persians of Aeschylus is the only surviving Greek tragedy which deals with contemporary events instead of mythology: the failure of the invasion of Greece by Xerxes in 480/479 BC. After examining the historical context of the representation, the essay provides an analysis, scene by scene, of the drama, also in relation to the two previous plays by Phrynichus, The Capture of Miletus and the Persians, both dealing with the clash between Greece and the Persian Empire.
- Published
- 2021
15. Il mito come filtro interpretativo della realtà: la guerra di Troia nella tragedia attica di V secolo
- Author
-
G. Manzoni, Pattoni, Maria Pia, Maria Pia Pattoni (ORCID:0000-0001-9132-2010), G. Manzoni, Pattoni, Maria Pia, and Maria Pia Pattoni (ORCID:0000-0001-9132-2010)
- Abstract
La guerra di Troia nei testi dei tragediografi attici, da Eschilo a Sofocle a Euripide.
- Published
- 2021
16. Bidirectional space to ground laser communication system for cubesat
- Author
-
V. Kuzkov, M. Abele, G. Manzoni, J. Vjaters, and A. Treijs
- Subjects
Computer science ,business.industry ,CubeSat ,Aerospace engineering ,Space (mathematics) ,business ,Free-space optical communication - Published
- 2018
- Full Text
- View/download PDF
17. Pretreatment with quercetin prevents changes in lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in hyperlipidemic rats
- Author
-
Daniela B.R. Leal, Josiane B.S. Braun, Jader B. Ruchel, Daniela F. Passos, Lívia G. Castilhos, Emerson André Casalli, Alessandra G. Manzoni, and Fátima Husein Abdalla
- Subjects
Male ,0301 basic medicine ,Adenosine Deaminase ,Clinical chemistry ,Clinical Biochemistry ,Flavonoid ,Hyperlipidemias ,Pharmacology ,Proinflammatory cytokine ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Hyperlipidemia ,medicine ,Animals ,heterocyclic compounds ,Lymphocytes ,cardiovascular diseases ,Pyrophosphatases ,Rats, Wistar ,Endothelial dysfunction ,Molecular Biology ,chemistry.chemical_classification ,Cholesterol ,business.industry ,nutritional and metabolic diseases ,Cell Biology ,General Medicine ,medicine.disease ,Rats ,030104 developmental biology ,chemistry ,Simvastatin ,030220 oncology & carcinogenesis ,Cytokines ,Quercetin ,business ,medicine.drug - Abstract
Hyperlipidemia (HL) is a condition associated with endothelial dysfunction and inflammatory disorders. Purinergic system ectoenzymes play an important role in modulating the inflammatory and immune response. This study investigated whether the preventive treatment with quercetin is able to prevent changes caused by hyperlipidemia in the purinergic system, through the activities of E-NTPDase and E-ADA in lymphocytes, and quantify the nucleotides and nucleoside, and the secretion of anti- and proinflammatory cytokines. Animals were divided into saline/control, saline/quercetin 5 mg/kg, saline/quercetin 25 mg/kg, saline/quercetin 50 mg/kg, saline/simvastatin (0.04 mg/kg), hyperlipidemia, hyperlipidemia/quercetin 5 mg/kg, hyperlipidemia/quercetin 25 mg/kg, hyperlipidemia/quercetin 50 mg/kg, and hyperlipidemia/simvastatin. Animals were pretreated with quercetin for 30 days and hyperlipidemia was subsequently induced by intraperitoneal administration of 500 mg/kg of poloxamer-407. Simvastatin was administered after the induction of hyperlipidemia. Lymphocytes were isolated and E-NTPDase and E-ADA activities were determined. Serum was separated for the cytokines and nucleotide/nucleoside quantification. E-NTPDase and E-ADA activities were increased in lymphocytes from hyperlipidemic rats and pretreatment with quercetin was able to prevent the increase in the activities of these enzymes caused by hyperlipidemia. Hyperlipidemic rats when receiving pretreatment with quercetin and treatment with simvastatin showed decreased levels of ATP and ADP when compared to the untreated hyperlipidemic group. The IFN-γ and IL-4 cytokines were increased in the hyperlipidemic group when compared with control group, and decreased when hyperlipidemic rats received the pretreatment with quercetin. However, pretreatment with quercetin was able to prevent the alterations caused by hyperlipidemia probably by regulating the inflammatory process. We can suggest that the quercetin is a promising compound to be used as an adjuvant in the treatment of hyperlipidemia.
- Published
- 2017
- Full Text
- View/download PDF
18. First Italian report on transitional care for highly complex urological diseases from pediatric to adult
- Author
-
M. Soligo, G. Carrieri, G. Manzoni, A. Cretì, Giovanni Mosiello, A. Cisternino, G. Creti, M. De Gennaro, and A. Giammò
- Subjects
medicine.medical_specialty ,business.industry ,Urology ,Medicine ,Urological Diseases ,Transitional care ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:RC870-923 ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,business ,Intensive care medicine ,lcsh:RC254-282 - Published
- 2020
- Full Text
- View/download PDF
19. Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment
- Author
-
E. Muraca, S. Ciardullo, S. Perra, F. Zerbini, A. Oltolini, R. Cannistraci, E. Bianconi, M. Villa, G. Manzoni, G. Lattuada, G. Perseghin, Muraca, E, Ciardullo, S, Perra, S, Zerbini, F, Oltolini, A, Cannistraci, R, Bianconi, E, Villa, M, Manzoni, G, Lattuada, G, and Perseghin, G
- Subjects
bariatric surgery, diabetes hypercotisolism ,MED/13 - ENDOCRINOLOGIA - Published
- 2020
20. Lipotoxicity-associated inflammation is prevented by guarana (
- Author
-
Jader B, Ruchel, Viviane M, Bernardes, Josiane B S, Braun, Alessandra G, Manzoni, Daniela F, Passos, Lívia G, Castilhos, Fátima H, Abdalla, Juliana S, de Oliveira, Cinthia M, de Andrade, Emerson A, Casali, Ivana B M, da Cruz, and Daniela B R, Leal
- Subjects
Inflammation ,Male ,Simvastatin ,Adenosine ,Dose-Response Relationship, Drug ,Anti-Inflammatory Agents ,Hyperlipidemias ,Rats ,Disease Models, Animal ,Adenosine Triphosphate ,Theophylline ,Caffeine ,Animals ,Theobromine ,Lymphocytes ,Rats, Wistar - Abstract
Hyperlipidemia causes lipotoxicity which prompts an inflammatory response linked to the development of cardiovascular diseases. Natural compounds have been receiving special attention for its potential to treat diseases, inexpensiveness, and safety. Guarana (
- Published
- 2019
21. Co-Nanoencapsulation of Vitamin D
- Author
-
Jean Lucas G, da Silva, Daniela F, Passos, Viviane M, Bernardes, Fernanda L, Cabral, Paulo G, Schimites, Alessandra G, Manzoni, Edilene Gadelha, de Oliveira, Cristiane, de Bona da Silva, Ruy Carlos Ruver, Beck, Matheus H, Jantsch, Roberto M, Maciel, and Daniela B R, Leal
- Subjects
Inflammation ,Drug Combinations ,Curcumin ,Neutrophils ,Purines ,Animals ,Capsules ,Lymphocytes ,Arthritis, Experimental ,Cholecalciferol ,Rats - Abstract
We analyzed the effects of a nanoencapsulated association of curcumin and vitamin D
- Published
- 2019
22. Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment
- Author
-
Muraca, E, Ciardullo, S, Perra, S, Zerbini, F, Oltolini, A, Cannistraci, R, Bianconi, E, Villa, M, Manzoni, G, Lattuada, G, Perseghin, G, E. Muraca, S. Ciardullo, S. Perra, F. Zerbini, A. Oltolini, R. Cannistraci, E. Bianconi, M. Villa, G. Manzoni, G. Lattuada, G. Perseghin, Muraca, E, Ciardullo, S, Perra, S, Zerbini, F, Oltolini, A, Cannistraci, R, Bianconi, E, Villa, M, Manzoni, G, Lattuada, G, Perseghin, G, E. Muraca, S. Ciardullo, S. Perra, F. Zerbini, A. Oltolini, R. Cannistraci, E. Bianconi, M. Villa, G. Manzoni, G. Lattuada, and G. Perseghin
- Published
- 2020
23. Modulation of reactive oxygen species production, apoptosis and cell cycle in pleural exudate cells of carrageenan-induced acute inflammation in rats by rutin
- Author
-
Alessandra G. Manzoni, João M. Bremm, Daniela B.R. Leal, Stephen A. Adefegha, and Juliana Sorraila de Oliveira
- Subjects
Lung Diseases ,0301 basic medicine ,Rutin ,Anti-Inflammatory Agents ,Apoptosis ,Inflammation ,Pharmacology ,Biology ,Carrageenan ,03 medical and health sciences ,chemistry.chemical_compound ,medicine ,Animals ,Humans ,Viability assay ,Rats, Wistar ,chemistry.chemical_classification ,Reactive oxygen species ,Cell Cycle ,General Medicine ,Cell cycle ,Pleural cavity ,Rats ,030104 developmental biology ,medicine.anatomical_structure ,Biochemistry ,chemistry ,Pleura ,Female ,medicine.symptom ,Reactive Oxygen Species ,Food Science - Abstract
The present study seeks to investigate the effect of rutin, a flavonoid compound in rat models of acute inflammation induced by carrageenan (CAR). Twenty-four female Wistar rats weighing 222-247 g received saline or 2% λ-carrageenan in the pleural cavity and treatment with rutin (80 mg kg-1) or saline by oral gavage for 21 days prior to the intrapleural induction of CAR. After 4 h of induction, the rats were euthanized, the plasma was prepared from the blood for the analysis of haematological parameters and the pleural exudate was obtained for the analysis of the total cell count, cell viability, reactive oxygen species (ROS) production, apoptosis and cell cycle. The result revealed that rutin exhibited anti-inflammatory effects by modulating the ROS level, apoptosis and cell cycle. This study indicates that rutin may exert a protective effect against ROS-mediated oxidative damage associated with an anti-inflammatory activity in rat models of acute inflammation.
- Published
- 2017
- Full Text
- View/download PDF
24. Total hip prosthesis complication, periprosthetic infection with external fistulizing due to Enterobacter cloacae complex multiple drugs resistance: A clinical case report
- Author
-
Stefania Anna Lucia Zanetti, Vittorio Mazzarello, Matthew Gavino Donadu, M. Corda, Carlo Doria, Alberto Sanna, Veronica Amorese, F. Pisanu, F. Marras, Maurizio Conti, F. Milia, Meloni Gb, Donatella Usai, D. Delogu, and G. Manzoni
- Subjects
medicine.medical_specialty ,Enterococci ,Fistula ,medicine.medical_treatment ,Periprosthetic ,Case Report ,Prosthesis ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Femur ,030212 general & internal medicine ,Microscopy ,030222 orthopedics ,biology ,Arthroprosthesis ,business.industry ,Surgical wound ,medicine.disease ,biology.organism_classification ,Surgery ,Implant ,Hip infection ,Complication ,business ,Enterobacter cloacae - Abstract
Highlights • The incidence of periprosthetic hip infections his just below 2%, and the Enterobacteriaceae are fairly rare, being the cause of infection in 3–6% of cases. • A 76 year old woman with multiple comorbidities underwent surgical implantation of endoprosthesis of the left hip. • Multidisciplinary diagnosis of a rare periprosthetic infection., Introduction The Enterobacter cloacae is a microorganism found in the intestinal flora of the majority of animals, including humans. Primary infections caused by E. cloacae are rare in immunocompetent patients, but are very common in hospital settings in newborns and immunocompromised patients, and can be aggravated by the insurgence of antibiotic resistance. The incidence of periprosthetic hip infections is just below 2%. Case presentation A 76 year old woman with multiple comorbidities underwent surgical implantation of intermediary total hip prosthesis of the left hip, in a different health facility, in February 2014, after the basicervical fracture of the upper femur extremity due to trauma. After an episode of dislocation of the prosthetic implant, in September 2014, she underwent a surgical operation to implant the acetabular component. A month later not in our facility, following a re-hospitalization for the dislocation of the arthroprosthesis, an infection from E. cloacae complex was discovered. After 2 years of chronic infection she came to our attention; the clinical picture featured coxalgia and secreting fistula in the surgical wound. Following a specific antibiotic therapy, carried out intravenously over the course of a month, we decided to intervene removing the left hip arthroprosthesis and placing an antibiotic spacer following the direction deduced from the antibiogram study of August 2016. Conclusion The patient was hospitalized in our facility and 2 months later she underwent another operation to remove the antibiotic spacer and to place a new total hip arthroprosthesis. Multiple swabs showed the complete healing from the infection, which was confirmed a couple of months later.
- Published
- 2017
- Full Text
- View/download PDF
25. NTPDase and 5′-nucleotidase as inflammatory markers in cattle naturally infected by Eurytrema coelomaticum
- Author
-
Fernanda A. Stedille, Aleksandro S. Da Silva, Ricardo E. Mendes, Ricardo Christ, Juscivete F. Fávero, Ester S. da Silva, Claiton I. Schwertz, Daniela B.R. Leal, Pedro H. Doleski, Alessandra G. Manzoni, Mateus Eloir Gabriel, Gustavo Machado, and Lenita M. Stefani
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Immunology ,Cattle Diseases ,Inflammation ,Trematode Infections ,Biology ,Dicrocoeliidae ,Microbiology ,Group A ,Parasite Load ,Group B ,5'-nucleotidase ,03 medical and health sciences ,Antigens, CD ,medicine ,Animals ,Immunology and Allergy ,Lymphocytes ,5'-Nucleotidase ,Pancreas ,chemistry.chemical_classification ,030102 biochemistry & molecular biology ,General Veterinary ,Apyrase ,Histology ,General Medicine ,Hyperplasia ,medicine.disease ,Molecular biology ,030104 developmental biology ,Infectious Diseases ,medicine.anatomical_structure ,Enzyme ,chemistry ,Cattle ,medicine.symptom ,Abattoirs ,Biomarkers ,Brazil - Abstract
The aim of this study was to evaluate seric NTPDase and 5′nucleotidase activities of cattle naturally infected by Eurytrema coelomanticum, as well as to correlate them to histopathological lesions in the pancreas and the degree of parasitism. Blood samples and pancreas of 51 bovines were collected on a slaughterhouse in Southern Brazil: 33 from cattle naturally infected by E. coelomanticum (the Group A), and 18 from uninfected animals (the Group B). Infected animals showed an average of 532 parasites per pancreas. In the pancreatic histology, ducts displayed hyperplasia, stenosis, proliferation of fibrous tissue, and interstitial inflammatory infiltration of lymphocytes. The serum from infected animals showed an increase in NTPDase activity when ATP was used as substrate (P < 0.001). For the ADP substrate, there was no difference between groups regarding NTPDase activity (P = 0.37), as well as 5′-nucleotidase activity (P = 0.27). Correlating NTPDase activity (ATP substrate) with the degree of histopathological lesions (rho = 0.66, P < 0.001) and the parasitic load on the pancreas (rho = 0.65, P < 0.001), a positive correlation was observed. Similar results were found between the degree of histopathological lesions and NTPDase activity (ADP substrate; rho = 0.29, P = 0.03), and 5′nucleotidase activity (rho = 0.35, P = 0.01). Based on the results of NTPDase and 5′nucleotidase enzymes in cattle naturally infected by E. coleomanticum, it is possible to suggest that these enzymes are involved in the modulation of inflammation, and they can act as markers of inflammatory response.
- Published
- 2016
- Full Text
- View/download PDF
26. Rutin and curcumin reduce inflammation, triglyceride levels and ADA activity in serum and immune cells in a model of hyperlipidemia
- Author
-
João M. Bremm, Matheus H Jantsch, Viviane M. Bernardes, Daniela F. Passos, Jean L.G. da Silva, Cinthia Melazzo de Andrade, Daniela B.R. Leal, Juliana Sorraila de Oliveira, Alessandra G. Manzoni, and Thaís R. Mann
- Subjects
0301 basic medicine ,Male ,Curcumin ,Adenosine Deaminase ,Rutin ,Inflammation ,Hyperlipidemias ,Poloxamer ,Pharmacology ,medicine.disease_cause ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Hyperlipidemia ,medicine ,Animals ,Rats, Wistar ,Molecular Biology ,Triglycerides ,Hypertriglyceridemia ,biology ,Chemistry ,nutritional and metabolic diseases ,Lipid metabolism ,Cell Biology ,Hematology ,medicine.disease ,Rats ,Oxidative Stress ,030104 developmental biology ,Myeloperoxidase ,biology.protein ,Molecular Medicine ,medicine.symptom ,Oxidative stress ,030215 immunology - Abstract
Hyperlipidemia is associated with endothelial dysfunction and inflammatory disorders. Adenosine and adenosine deaminase (ADA) modulate immune responses and lipid metabolism. Curcumin and rutin are polyphenols with antioxidant, anti-inflammatory, and hypolipidemic effects. We evaluated the action of rutin and curcumin in the lipid levels and inflammation, as well as their effect on ADA activity in serum, lymphocytes, platelets, and neutrophils of hyperlipidemic rats. Adult male Wistar rats pretreated with curcumin and/or rutin for 30 days were submitted to Poloxamer-407- induced hyperlipidemia. Biochemical, hematological, and oxidative stress parameters, as well as serum and extracellular ADA activity, were performed 36h post-induction. Hyperlipidemia was confirmed by the increase in total cholesterol (TC) and triglycerides (TG). Hematological alterations, elevated reactive oxygen species (ROS) levels, and increased myeloperoxidase (MPO) and ADA activities were observed in hyperlipidemic rats. Curcumin and the curcumin/rutin association decreased TG and increased high-density lipids (HDL) levels. The pretreatments prevented changes in the hematological parameters, decreased the activities of MPO in plasma and ADA in serum and cells. Cholesterol and ROS levels were not altered by the pretreatments. Our results show that pretreatments with rutin and/or curcumin prevent the hyperlipidemia-induced inflammation. Pretreatments with curcumin and/or rutin are potential complementary therapies in the prevention of hypertriglyceridemia and inflammation.
- Published
- 2018
27. Antioxidant, hepatoprotective, genoprotective, and cytoprotective effects of quercetin in a murine model of arthritis
- Author
-
Karine Lanes da Silveira, Ivana Beatrice Mânica da Cruz, Fátima Husein Abdalla, Daniela F. Passos, Renata da Silva Pereira Saccol, Emerson André Casali, Cinthia Melazzo de Andrade, Alessandra G. Manzoni, Fernanda Barbisan, Guilherme Lopes Dornelles, Juliana Sorraila de Oliveira, and Daniela B.R. Leal
- Subjects
0301 basic medicine ,Antioxidant ,medicine.medical_treatment ,Freund's Adjuvant ,Arthritis ,Pharmacology ,medicine.disease_cause ,Biochemistry ,Thiobarbituric Acid Reactive Substances ,Antioxidants ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Animals ,heterocyclic compounds ,Lymphocytes ,Rats, Wistar ,Molecular Biology ,chemistry.chemical_classification ,Reactive oxygen species ,biology ,Superoxide Dismutase ,Cell Biology ,Glutathione ,medicine.disease ,Catalase ,Rats ,Disease Models, Animal ,Oxidative Stress ,030104 developmental biology ,chemistry ,Liver ,030220 oncology & carcinogenesis ,biology.protein ,Female ,Quercetin ,Comet Assay ,Lipid Peroxidation ,Reactive Oxygen Species ,Genotoxicity ,Oxidative stress ,DNA Damage ,Mutagens - Abstract
Rheumatoid arthritis is a highly debilitating inflammatory autoimmune disease which is characterized by joint destruction. The present study sought to investigate the effect of quercetin in rats with complete Freund's adjuvant-induced arthritis. Animals were divided into control/saline, control/quercetin (5 mg/kg, 25 mg/kg, and 50 mg/kg) arthritis/saline, and arthritis/quercetin (5 mg/kg, 25 mg/kg, and 50 mg/kg); the treatments were administered for 45 days. Biochemical, oxidative stress, genotoxicity, and cytotoxicity parameters were evaluated. All doses of quercetin reduced the levels of aspartate aminotransferase, thiobarbituric acid-reactive substances, and reactive oxygen species; however, only treatment with 25 or 50 mg/kg increased catalase activity. Total thiol and reduced glutathione levels were not significantly affected by the induction nor by the treatments. Genotoxicity assessed by DNA damage, and cytotoxicity through picogreen assay, decreased after treatments with quercetin. Our results present evidence of the antioxidant, cytoprotective, genoprotective and hepatoprotective, and effects of quercetin, demonstrating its potential as a candidate for coadjuvant therapy.
- Published
- 2018
28. Effect of quercetin on E-NTPDase/E-ADA activities and cytokine secretion of complete Freund adjuvant-induced arthritic rats
- Author
-
Alessandra G. Manzoni, Nara Maria Beck Martins, Lívia G. Castilhos, Juliana Sorraila de Oliveira, Daniela B.R. Leal, Lara Vargas Becker, Emerson André Casali, Stephen A. Adefegha, Fátima Husein Abdalla, Ana Paula Visintainer Coelho, Leonardo Lanes da Silveira, Karine Lanes da Silveira, and Renata da Silva Pereira Saccol
- Subjects
0301 basic medicine ,Clinical Biochemistry ,Flavonoid ,Freund's Adjuvant ,Arthritis ,Pharmacology ,Biochemistry ,AMP Deaminase ,Arthritis, Rheumatoid ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,Medicine ,Animals ,Edema ,heterocyclic compounds ,Enzyme Inhibitors ,Rats, Wistar ,chemistry.chemical_classification ,Adenosine Triphosphatases ,biology ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Cell Biology ,General Medicine ,medicine.disease ,Adenosine ,Rats ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Rheumatoid arthritis ,Myeloperoxidase ,biology.protein ,Cytokines ,Cytokine secretion ,Female ,Quercetin ,business ,medicine.drug - Abstract
The effect of quercetin was assessed in rats induced with complete Freund adjuvant (CFA). Arthritis scores, paw oedema, latency, activities of myeloperoxidase (MPO), ectonucleoside triphosphate diphosphohydrolase (E-NTPDase), and ectoadenosine deaminase (E-ADA) in lymphocytes were determined. Furthermore, nucleotide and nucleoside levels as well as the secretion of pro- and anti-inflammatory cytokines were evaluated. Animals were treated with saline and quercetin in doses of 5, 25, and 50 mg/kg for 45 days. The result revealed that quercetin (50 mg/kg) reduced arthritis score and paw oedema, and increased the latency in the thermal hyperalgesia test. Histopathological analysis showed that all the doses of quercetin reduced infiltration of inflammatory cells. MPO activity was increased in the arthritis group; however, quercetin reduced this activity. E-NTPDase activity was increased in lymphocytes of arthritis rats, and treatment with quercetin reversed this increase. However, E-ADA activity was reduced in the arthritis group, and treatment with quercetin modulated the activity of this enzyme in arthritis rat groups. Serum adenosine levels were increased in arthritis, and the levels were lowered with quercetin treatment. Quercetin treatment in arthritis groups decreased the elevated levels of cytokines in the arthritis control group. Thus, quercetin demonstrated an anti-inflammatory effect, and this flavonoid may be a promising natural compound for the treatment of arthritis. SIGNIFICANCE OF THE STUDY: Quercetin may represent a potential therapeutic compound in the treatment of rheumatoid arthritis. Findings from this study indicate that quercetin suppresses swelling and attenuates the underlying inflammatory responses. This is the first report where quercetin was shown to modulate the immune response to arthritis via attenuation of the purinergic system (E-NTPDase and E-ADA activities) and the levels of IFN-gamma and IL-4. Thus, this work is relevant to basic research and may be translated into clinical practice.
- Published
- 2018
29. Diphenyl diselenide modulates nucleotidases, reducing inflammatory responses in the liver of Toxoplasma gondii-infected mice
- Author
-
Cesar Eduardo Jacintho Moritz, Pedro H. Doleski, Ricardo E. Mendes, Vanessa S. Machado, Fernanda Silveira Flores Vogel, Giovana Camillo, Alessandra G. Manzoni, Emerson André Casali, Daniela B.R. Leal, Nathieli B. Bottari, Lenita M. Stefani, Ana C. A. Rocha, and Aleksandro Schafer da Silva
- Subjects
0301 basic medicine ,Purine ,medicine.medical_specialty ,Inflammation ,Biology ,Group A ,Pathogenesis ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Nucleotidases ,Internal medicine ,Nucleotidase ,Organoselenium Compounds ,medicine ,Benzene Derivatives ,Animals ,Molecular Biology ,Diphenyl diselenide ,Purinergic receptor ,Toxoplasma gondii ,Cell Biology ,biology.organism_classification ,030104 developmental biology ,Endocrinology ,chemistry ,Liver ,Purines ,030220 oncology & carcinogenesis ,Immunology ,Original Article ,medicine.symptom ,Toxoplasmosis - Abstract
The aim of this study was to verify the effect of diphenyl diselenide (PhSe)2 on hepatic nucleotidases and on the concentration of purines in mice infected by Toxoplasma gondii. The animals were divided into four groups: Group A (uninfected), Group B (uninfected and treated with (PhSe)2), Group C (infected), and Group D (infected and treated with (PhSe)2). The inoculation (groups C and D) was performed with 50 cysts of T. gondii (ME-49 strain). Mice from groups B and D were treated with 5 μmol kg−1 of (PhSe)2. Liver tissue from infected mice showed less severe inflammation, elevated ATP/ADO ratio, elevated NTPDase, 5′nucleotidase, and ADA activities compared to the uninfected group (Group A; P
- Published
- 2017
30. Treatment with 3'-deoxyadenosine and deoxycoformycin in mice infected by Trypanosoma cruzi and its side effect on purinergic enzymes
- Author
-
Matheus D. Baldissera, Thirssa H. Grando, Aleksandro Schafer da Silva, Lenita M. Stefani, Maria Isabel de Azevedo, Alessandra G. Manzoni, Ricardo E. Mendes, Lucas T. Gressler, Luan Cleber Henker, Guilherme M. do Carmo, Pedro H. Doleski, Daniela B.R. Leal, Silvia Gonzalez Monteiro, and Mariângela F. de Sá
- Subjects
0301 basic medicine ,Nucleotidase activity ,Adenosine Deaminase ,Trypanosoma cruzi ,030231 tropical medicine ,Antiprotozoal Agents ,Parasitemia ,Pharmacology ,Microbiology ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Deoxyadenosine ,parasitic diseases ,medicine ,Animals ,Chagas Disease ,Pyrophosphatases ,biology ,Cordycepin ,Deoxyadenosines ,Purinergic receptor ,biology.organism_classification ,medicine.disease ,Adenosine ,030104 developmental biology ,Infectious Diseases ,chemistry ,Immunology ,Deoxycoformycin ,Drug Therapy, Combination ,Female ,Pentostatin ,medicine.drug - Abstract
The aim of this study was to evaluate the efficacy of 3'-deoxyadenosine and deoxycoformycin combination in the treatment of mice infected by T. cruzi, as well as to verify the influence of the treatment on purinergic enzymes. Heart and serum samples were collected from 60 mice (30 infected and 30 uninfected) at day 12 post-infection. To verify treatment efficacy, parasitemia was monitored, and the treatment with 3'-deoxy adenosine and deoxycoformycin combination was able to reduce it, but had no curative effect on mice. Seric activities of NTPDase (ATP and ADP substrate) and ADA were increased significantly in untreated mice infected by T. cruzi compared to the negative control, as well as mice treated with 3'-deoxyadenosine and deoxycoformycin (alone or combined) modulated the activity of NTPDase (ATP and ADP substrate), preventing them from increasing in infected animals (activity similar to healthy animals). Treatment with deoxycoformycin alone and associated with 3'-deoxyadenosine modulated the activity of ADA preventing them from increasing in infected animals. However, seric activities of ADA in mice treated with 3'-deoxyadenosine (cordycepin) alone does not modify the ADA activity compared with infected and non-treated mice. However, the 5'-nucleotidase activity decreased significantly in infected untreated animals and the same occurred in infected and treated animals with deoxycoformycin and 3'-deoxyadenosine. However, treatment with deoxycoformycin associated with 3'-deoxyadenosine preventing them from decreasing the 5'-nucleotidase activity. Therefore, we conclude that the treatments did not have curative success for mice infected by T. cruzi. However, the treatments were able to modulate the purinergic enzymes during the infection by T. cruzi, which may contribute to reduce the inflammatory damage in heart.
- Published
- 2017
31. Robot-assisted laparoscopic pyeloplasty (RALP) in children with horseshoe kidneys: Results of a multicentric study
- Author
-
S. Venturini, Mariapina Cerulo, G. Manzoni, Selcuk Silay, Lorenzo Masieri, Ciro Esposito, Thomas Blanc, and Maria Escolino
- Subjects
medicine.medical_specialty ,business.industry ,Urology ,medicine ,Laparoscopic pyeloplasty ,business ,Surgery ,Horseshoe (symbol) - Published
- 2019
- Full Text
- View/download PDF
32. High Frequency GNSS Measurements for Structural Monitoring Applications
- Author
-
Raffaela Cefalo, Tatiana Sluga, Salvatore Noe, G. Manzoni, O. Gervasi et al., Cefalo, Raffaela, Manzoni, Giorgio, Noe', Salvatore, and Sluga, Tatiana
- Subjects
Deformation monitoring ,Vibration ,Dynamic deformation ,GNSS ,GNSS applications ,structural monitoring ,Satellite system ,Structural monitoring ,Geology ,Remote sensing - Abstract
Dynamic deformation monitoring of structures such as long bridges, towers, and tall buildings, for the purpose of determining structural vibrations, is possible using Global Navigation Satellite System (GNSS) (Lovse, J. W. et al., 1995). Starting from 1998, high frequency GNSS measurements have been performed at the Department of Civil Engineering, University of Trieste, Italy, on special civil engineering structures: chimneys, bridges, wind-power towers simulators for the analysis of dynamic behavior and structural vibration monitoring. Using 10, 20 and 50 Hz GPS and GPS+GLONASS receivers, different tests have been performed using simulators built on purpose for the experiments and in real conditions on high structures. A report of the tests performed on a 100 m chimney in Trieste, Italy during strong wind conditions from 1998 to 2002 and using a simulator of elliptical movements for applications to wind-powers vibrations monitoring, in the framework of Italian COFIN98 Aerogen Project, in the years 2008 – 2010, are herein reported.
- Published
- 2017
33. Ultrafast dynamics in unaligned MWCNTs
- Author
-
G Manzoni, S Ponzoni, G Galimberti, M Scarselli, O Pulci, L Camilli, L Matthes, P Castrucci, and S Pagliara
- Subjects
Physics::Optics - Abstract
The relaxation dynamics of unaligned multi-walled carbon nanotubes decorated with metallic nanoparticles have been studied by using transient optical measurements. The fast dynamics due to the short-lived free-charge carriers excited by the pump are not affected by the presence of nanoparticles. Conversely, a second long dynamics, absent in bare carbon nanotubes, appears only in the decorated samples. A combination of experiment and theory allows us to ascribe this long dynamics to relaxation channels involving electronic states localized at the tube nanoparticle interface.
- Published
- 2016
34. New aryltellurenyl iodides with uncommon valences: synthetic and structural characteristics of [RTeTe[I.sub.2]R], [[R.sub.2]TeTe[R.sub.2]][[Tesub.4][I.sub.14]], and [RTe(I)[I.sub.2]] (R = 2,6-dimethoxyphenyl)
- Author
-
de Oliveira, G. Manzoni, Faoro, Eliandro, and Lang, E. Schulz
- Subjects
Oxidation-reduction reaction -- Analysis ,Tellurium -- Chemical properties ,Tellurium -- Structure ,Valence -- Research ,Chemistry - Published
- 2009
35. Radiofrequency Identification Tagging in Ornamental Shrubs: An Application in Rose
- Author
-
Alessandra Panattoni, Andrea Luvisi, E. Rinaldelli, Barbara Gini, G. Manzoni, R. Bandinelli, Mario Pagano, Enrico Triolo, Luvisi, Andrea, Panattoni, A., Bandinelli, R., Rinaldelli, E., Pagano, M., Gini, B., Manzoni, G., and Triolo, E.
- Subjects
Rose (mathematics) ,endocrine system ,biology ,food and beverages ,Horticulture ,biology.organism_classification ,Aesthetic value ,Agronomy ,Plant production ,Lateral shoot ,Shoot ,Ornamental plant ,Cultivar ,Cane - Abstract
Plant tagging using radiofrequency identification (RFID) microchips is attractive for ornamental shrubs, such as rose (Rosa spp.), due to their high market value, wide distribution, health certification system, and numerous uses. Differently from other woody species for which methods of microchip implantation have been tested, rose tagging requires the possibility of insertion within canes of less than 10 mm diameter, such as those typically found in the rose nursery setting. Moreover, the possibility of tagging after grafting without changing common plant production procedures and aesthetic value are important considerations. Toward this aim, a new method of microchip insertion was developed. To test its effects on roses, two cultivars were subjected to a tagging procedure, and histological observations of tissues around the microchip and growth analysis of plant canes were performed. Microchip implantation did not cause xylem necrosis in 8- to 9-mm-diameter canes, but in lower diameter canes wilt of the lateral shoot and detriments in growth were observed compared with control plants. The tagged roses were tracked by a database developed for rose information, field log, and botanical sheet retrieval. Our findings suggest that rose plants can be safely tagged with a RFID microchip following suitable selection of cane calliper as early as the nursery phase without negative effects on plant appearance.
- Published
- 2010
- Full Text
- View/download PDF
36. Variabilidade genética na região its do rDNA de isolados de trichoderma spp. (Biocontrolador) e Fusarium oxysporum f. sp. Chrysanthemi Genetic variability in rDNA ITS region of Trichoderma spp. (biocontrole agent) and Fusarium oxysporum f. sp. chrysanthemi isolates
- Author
-
Josiane Pacheco Menezes, Manoeli Lupatini, Zaida Inês Antoniolli, Elena Blume, Emanuele Junges, and Clarice G. Manzoni
- Subjects
molecular characterization ,Soilborne fungi ,análises de DNA ,sequences ,sequências ,DNA analysis ,lcsh:Agriculture (General) ,Fungos de solo ,endonucleases ,lcsh:S1-972 ,caracterização molecular - Abstract
A análise de características morfológicas e culturais podem não ser suficientes para uma caracterização precisa das espécies de Trichoderma e Fusarium. Objetivou-se, neste trabalho, caracterizar a região do Espaço Interno Transcrito (ITS) do rDNA dos isolados UFSMT15.1, UFSMT16 e UFSMT17 de Trichoderma spp. utilizados no biocontrole de Fusarium oxysporum f. sp. chrysanthemi (isolado) UFSMF6. A extração de DNA de cada isolado foi realizada a partir de micélio produzido em meio líquido Batata-Dextrose. As amostras de DNA genômico foram submetidas à Reação em Cadeia da Polimerase (PCR) com os oligonucleotídeos iniciadores universais ITS1 e ITS4 e o produto gerado foi sequenciado. Os fragmentos gerados pela amplificação da PCR foram tratados com as enzimas de restrição HaeIII, HinfI e MboI. As regiões ITS1, ITS2 e 5.8S do rDNA desses isolados fúngicos foram amplificadas com sucesso. A região ITS dos isolados UFSMT15.1, UFSMT16 e UFSMT17 de Trichoderma e o isolado UFSMF6 de Fusarium apresentaram uma banda simples com um fragmento de aproximadamente 600 pares de base (pb). As enzimas de restrição HaeIII, HinfI e MboI geraram polimorfismo de bandas entre os isolados. Com base nas análises da sequência de DNA, os isolados UFSMT15.1, UFSMT16, UFSMT17 e UFSMF6 apresentaram maior similaridade com as espécies Trichoderma koningiopsis, Hypocrea virens, Hypocrea lixii e Fusarium oxysporum, respectivamente.The analysis of morphological and cultural characteristics may not enough for the characterization of the species of Trichoderma and Fusarium. The aim of this work was to characterize the Internal Transcribed Spacer (ITS) region of the rDNA of UFSMT15.1, UFSMT16 and UFSMT17 isolates of Trichoderma spp. used in the biocontrol of Fusarium oxysporum f. sp. chrysanthemi UFSMF6. DNA extraction of each isolate was accomplished starting from hyphae produced in liquid medium Potato-Dextrose-Agar. The samples of genomic DNA were submitted to the Polymerase Chain Reaction (PCR) with the primers ITS1 and ITS4, and the product was sequenced. The fragments generated from PCR amplification were digested with the restriction enzymes HaeIII, HinfI and MboI. The ITS region of the Trichoderma's isolates UFSMT15.1, UFSMT16 and UFSMT17 and the Fusarium UFSMF6 isolate showed a simple band with a fragment with 600 base pairs (bp) approximately. The restriction enzymes HaeIII, HinfI and MboI generated band polymorphism among the isolates. The isolates UFSMT15.1, UFSMT16, UFSMT17 and UFSMF6 showed high similarity whit Trichoderma koningiopsis, Hypocrea virens, Hypocrea lixii and Fusarium oxysporum species, respectively.
- Published
- 2010
37. In-orbit offline estimation of the residual magnetic dipole biases of the POPSAT-HIP1 nanosatellite
- Author
-
Y. L. Brama, G. Manzoni, Stefano Seriani, Paolo Gallina, Seriani, Stefano, Brama, Y. L., Gallina, Paolo, and Manzoni, G.
- Subjects
Engineering ,Residual magnetic moment ,Magnetometer ,Cubesat ,Aerospace Engineering ,Nanosatellite ,02 engineering and technology ,010502 geochemistry & geophysics ,Residual ,01 natural sciences ,law.invention ,Igrf ,Attitude control ,Control theory ,law ,0202 electrical engineering, electronic engineering, information engineering ,0105 earth and related environmental sciences ,Genetic algorithm ,Magnetic field ,Spacecraft ,business.industry ,020208 electrical & electronic engineering ,Transmitter ,Physics::Space Physics ,Orbit (dynamics) ,Satellite ,business ,Magnetic dipole - Abstract
The nanosatellite POPSAT-HIP1 is a Cubesat-class spacecraft launched on the 19th of June 2014 to test cold-gas based micro-thrusters; it is, as of April 2015, in a low Earth orbit at around 600 km of altitude and is equipped, notably, with a magnetometer. In order to increment the performance of the attitude control of nanosatellites like POPSAT, it is extremely useful to determine the main biases that act on the magnetometer while in orbit, for example those generated by the residual magnetic moment of the satellite itself and those originating from the transmitter. Thus, we present a methodology to perform an in-orbit offline estimation of the magnetometer bias caused by the residual magnetic moment of the satellite (we refer to this as the residual magnetic dipole bias, or RMDB). The method is based on a genetic algorithm coupled with a simplex algorithm, and provides the bias RMDB vector as output, requiring solely the magnetometer readings. This is exploited to compute the transmitter magnetic dipole bias (TMDB), by comparing the computed RMDB with the transmitter operating and idling. An experimental investigation is carried out by acquiring the magnetometer outputs in different phases of the spacecraft life (stabilized, maneuvering, free tumble). Results show remarkable accuracy with an RMDB orientation error between 3.6 ° and 6.2 ° , and a module error around 7 % . TMDB values show similar coherence values. Finally, we note some drawbacks of the methodologies, as well as some possible improvements, e.g. precise transmitter operations logging. In general, however, the methodology proves to be quite effective even with sparse and noisy data, and promises to be incisive in the improvement of attitude control systems.
- Published
- 2016
38. CMS Collaboration
- Author
-
Aarrestad, T.K. Abbaneo, D. Abbiendi, G. Abbrescia, M. Abdelalim, A.A. Abdullin, S. Abdulsalam, A. Abu Zeid, S. Ackert, A. Acosta, D. Acosta, J.G. Adair, A. Adam, W. Adams, J.R. Adams, M.R. Adams, T. Adiguzel, A. Adzic, P. Afanasiev, S. Agapitos, A. Aggleton, R. Agram, J.-L. Ahmad, A. Ahmad, M. Ahmad, M. Ahmed, I. Ahuja, S. Akbiyik, M. Akchurin, N. Akgun, B. Akin, I.V. Albajar, C. Albrow, M. Alcaraz Maestre, J. Aldá Júnior, W.L. Aldaya Martin, M. Alderweireldt, S. Aleksandrov, A. Alexander, J. Alimena, J. Alunni Solestizi, L. Alverson, G. Alves, F.L. Alves, G.A. Alyari, M. Amapane, N. Amsler, C. Anagnostou, G. Anderson, D. Anderson, I. Andrea, J. Andreev, V. Andreev, Y. Andrews, M.B. Androsov, K. Anelli, C. Antonelli, L. Antropov, I. Antunovic, Z. Apanasevich, L. Apollinari, G. Appelt, E. Apresyan, A. Apyan, A. Arcaro, D. Arcidiacono, R. Arenton, M.W. Argiro, S. Arneodo, M. Arora, S. Asavapibhop, B. Asawatangtrakuldee, C. Asilar, E. Asin, I. Askew, A. Ata, M. Attikis, A. Aubin, A. Auffray, E. Autermann, C. Auzinger, G. Avdeeva, E. Avery, P. Avetisyan, A. Avila, C. Awad, A. Azarkin, M. Azhgirey, I. Aziz, T. Azzi, P. Azzolini, V. Azzurri, P. Baarmand, M.M. Baber, M. Bacchetta, N. Bachmair, F. Bachtis, M. Baden, A. Baffioni, S. Bagliesi, G. Baillon, P. Bainbridge, R. Bakhshiansohi, H. Ball, A.H. Ball, F. Ban, Y. Banerjee, S. Banerjee, S. Bäni, L. Bansal, S. Barbagli, G. Barberis, E. Barbieri, R. Bargassa, P. Baringer, P. Barker, A. Barnes, V.E. Barnett, B.A. Barney, D. Baron, O. Barone, L. Barria, P. Bartek, R. Barth, C. Bartók, M. Bartosik, N. Basegmez, S. Baskakov, A. Battilana, C. Baty, A. Bauerdick, L.A.T. Baumgartel, D. Baus, C. Bayshev, I. Bean, A. Beauceron, S. Beaudette, F. Beck, L. Beernaert, K. Behnamian, H. Behnke, O. Behrens, U. Bein, S. Beirão Da Cruz E Silva, C. Belchior Batista Das Chagas, E. Belforte, S. Beliy, N. Belknap, D.A. Bell, A.J. Bellan, R. Belloni, A. Beluffi, C. Belyaev, A. Belyaev, A. Benaglia, A. Benato, L. Bencze, G. Bendavid, J. Benedetti, D. Benelli, G. Benhabib, L. Beni, N. Benitez, J.F. Benucci, L. Benussi, L. Benvenuti, A.C. Beranek, S. Beretvas, A. Bergauer, T. Berger, J. Beri, S.B. Bernardes, C.A. Bernardini, J. Bernet, C. Berruti, G.M. Berry, D. Berry, E. Berryhill, J. Bertl, W. Besancon, M. Betchart, B. Betts, R.R. Bhardwaj, A. Bhat, P.C. Bhatnagar, V. Bhattacharya, S. Bhattacharya, S. Bhopatkar, V. Bhowmik, S. Bialkowska, H. Bian, J.G. Bianchini, L. Bianco, S. Biasini, M. Bierwagen, K. Biino, C. Bilei, G.M. Bilin, B. Bilki, B. Bilmis, S. Bitioukov, S. Blekman, F. Blobel, V. Bloch, D. Bloch, P. Bloom, K. Bluj, M. Blumenfeld, B. Boccali, T. Bocci, A. Bochenek, J. Bodek, A. Bodlak, M. Boimska, B. Boletti, A. Bolla, G. Bonacorsi, D. Bonato, A. Bondu, O. Boos, E. Bornheim, A. Borras, K. Bortignon, P. Bortoletto, D. Borzou, A. Bose, S. Bose, T. Böser, C. Botta, C. Boudoul, G. Bouhali, O. Bourilkov, D. Bouvier, E. Bradmiller-Feld, J. Braghieri, A. Braibant-Giacomelli, S. Branca, A. Brandstetter, J. Brandt, S. Branson, J.G. Breedon, R. Breto, G. Breuker, H. Brew, C. Brianza, L. Brigliadori, L. Brigljevic, V. Brinkerhoff, A. Brinson, J. Brito, L. Brochero Cifuentes, J.A. Brochet, S. Brodski, M. Brom, J.-M. Brona, G. Brondolin, E. Brooke, J.J. Brown, R.M. Brun, H. Bruner, C. Bruno, G. Buchmuller, O. Bucinskaite, I. Bundock, A. Bunin, P. Bunkowski, K. Bunn, J. Buontempo, S. Burgmeier, A. Burkett, K. Burt, K. Burton, D. Busson, P. Busza, W. Butler, J.N. Butler, P.H. Buttignol, M. Butz, E. Bylinkin, A. Bylsma, B. Byszuk, A. Cabrera, A. Cabrillo, I.J. Cadamuro, L. Caillol, C. Cakir, A. Calabria, C. Calamba, A. Calderon, A. Calderon De La Barca Sanchez, M. Cali, I.A. Call, K. Calligaris, L. Calpas, B. Calvelli, V. Calvert, B. Calvo, E. Caminada, L. Campagnari, C. Campanini, R. Campbell, A. Camporesi, T. Candelise, V. Canelli, M.F. Cankocak, K. Capiluppi, P. Cappello, G. Caputo, C. Cardaci, M. Carlsmith, D. Carlson, B. Carnes, A. Carrillo Montoya, C.A. Carrillo Moreno, S. Cartiglia, N. Carvalho, W. Carver, M. Casal, B. Casarsa, M. Casasso, S. Casimiro Linares, E. Castaldi, R. Castaneda Hernandez, A. Castello, R. Castiñeiras De Saa, J.R. Castilla-Valdez, H. Castro, A. Caudron, A. Cavallari, F. Cavallo, F.R. Cavallo, N. Cavanaugh, R. Ceard, L. Celik, A. Centis Vignali, M. Cepeda, M. Cerati, G.B. Cerci, S. Cerminara, G. Cerrada, M. Chabert, E.C. Chamizo Llatas, M. Chang, P. Chang, Y.H. Chang, Y.W. Chanon, N. Chao, Y. Chaparro Sierra, L.F. Chapon, E. Charaf, O. Charlot, C. Chasco, M. Chatterjee, A. Chatterjee, K. Chatterjee, R.M. Chauhan, S. Chauhan, S. Chaves, J. Chawla, R. Chen, G.M. Chen, H.S. Chen, K.F. Chen, K.H. Chen, M. Chen, P.H. Chen, Y. Chen, Z. Cheng, T. Cherepanov, V. Chertok, M. Cheung, H.W.K. Chhibra, S.S. Chierici, R. Chinellato, J. Chiochia, V. Chiorboli, M. Chlebana, F. Choi, M. Choi, S. Choi, Y. Chou, J.P. Choudhary, B.C. Choudhury, S. Chu, J. Chudasama, R. Chwalek, T. Ciangottini, D. Cieri, D. Cihangir, S. Cimmino, A. Ciocci, M.A. Cirkovic, P. Citron, M. Cittolin, S. Ciulli, V. Civinini, C. Claes, D.R. Clare, R. Clarida, W. Clarke, C. Clement, E. Clerbaux, B. Cockerill, D.J.A. Codispoti, G. Colafranceschi, S. Colaleo, A. Cole, J.E. Colino, N. Collard, C. Colling, D. Colombo, F. Contardo, D. Conte, E. Contreras-Campana, C. Contreras-Campana, E. Conway, J. Conway, R. Cooper, S.I. Cornelis, T. Corpe, L. Correa Martins Junior, M. Cossutti, F. Costa, M. Costa, S. Costanza, F. Coubez, X. Couderc, F. Coughlan, J.A. Courbon, B. Cousins, R. Covarelli, R. Cowden, C. Cox, B. Cox, P.T. Creanza, D. Cripps, N. Cristella, L. Crucy, S. Cuevas, J. Cuffiani, M. Cumalat, J.P. Curry, D. Cussans, D. Custódio, A. Cutts, D. Czellar, S. D'Agnolo, R.T. D'Alessandro, R. D'Alfonso, M. D'Hondt, J. Da Costa, E.M. Da Silveira, G.G. Dabrowski, A. Daci, N. Dahmes, B. Dahms, T. Dalchenko, M. Dall'Osso, M. Dallavalle, G.M. Damgov, J. Daponte, V. Das, S. Daskalakis, G. Dasu, S. Dauncey, P. David, A. Davies, G. Davignon, O. De Roeck, A. De Souza Santos, A. De Wit, A. De Cosa, A. De La Cruz, B. De Oliveira Martins, C. De Jesus Damiao, D. De La Cruz-Burelo, E. De Wolf, E.A. De Guio, F. De Lentdecker, G. De Bruyn, I. De Gruttola, M. De Mattia, M. De Palma, M. De Filippis, N. De Castro Manzano, P. De Visscher, S. De Boer, W. Degano, A. Deiters, K. Dejardin, M. Del Re, D. Delaere, C. Delannoy, A.G. Delgado, A. Delgado Peris, A. Dell'Orso, R. Della Ricca, G. Della Negra, M. Demaria, N. Demina, R. Demiragli, Z. Demiroglu, Z.S. Denegri, D. Depasse, P. Derdzinski, M. Dermenev, A. Deroover, K. Descroix, A. Dev, N. Dewanjee, R.K. Dey, S. Dhingra, N. Di Francesco, A. Di Mattia, A. Di Marco, E. Di Matteo, L. Di Guida, S. Diamond, B. Diemoz, M. Dierlamm, A. Dietz, C. Dietz-Laursonn, E. Diez Pardos, C. Dildick, S. Dilsiz, K. Dimitrov, A. D'imperio, G. Dinardo, M.E. Dishaw, A. Dissertori, G. Dittmann, J. Dittmar, M. Dittmer, S. Doan, T.H. Dobson, M. Dobur, D. Dodd, L. Dogra, S. Dolen, J. Dolinska, G. Dominguez, A. Domínguez Vázquez, D. Donato, S. Donegà, M. Dooling, S. Dordevic, M. Dorigo, T. Dorland, T. Dorney, B. Doroba, K. Dozen, C. Draeger, A.R. Dragicevic, M. Dragoiu, C. Dremin, I. Driga, O. Du, R. Duarte, J. Dube, S. Duchardt, D. Dudenas, V. Dudero, P.R. Dugad, S. Duggan, D. Dumanoglu, I. Dunne, P. Dünser, M. Dupont, N. Durgut, S. Duric, S. Durkin, L.S. Dutta, D. Dutta, S. Dutta, V. Eckerlin, G. Ecklund, K.M. Eckstein, D. Edelhoff, M. Eerola, P. Eggert, N. Eichhorn, T. El Mamouni, H. El Sawy, M. Eller, P. Elliott-Peisert, A. Ellison, J. Elmer, P. Elvira, V.D. Elwood, A. Eminizer, N. Endres, M. Eno, S.C. Epshteyn, V. Erbacher, R. Erdmann, M. Erdmann, W. Erdogan, Y. Erdweg, S. Erfle, J. Erö, J. Ershov, A. Escalante Del Valle, A. Esch, T. Eshaq, Y. Esposito, M. Etesami, S.M. Eusebi, R. Evangelou, I. Evans, A. Evdokimov, O. Everaerts, P. Fabbri, F. Fabbri, F. Fabbro, B. Fabozzi, F. Faccioli, P. Fagot, A. Fahim, A. Fan, J. Fanfani, A. Fangmeier, C. Fanò, L. Fantasia, C. Fanzago, F. Farrell, C. Fasanella, D. Fasanella, G. Faulkner, J. Faure, J.L. Favaro, C. Favart, D. Favart, L. Fay, J. Fedi, G. Fehling, D. Felcini, M. Feld, L. Feng, L. Ferapontov, A. Ferbel, T. Ferencek, D. Ferguson, T. Ferguson, W. Fernandez Bedoya, C. Fernandez Menendez, J. Fernández Ramos, J.P. Fernandez, M. Fernandez Perez Tomei, T.R. Ferraioli, C. Ferreira Parracho, P.G. Ferri, F. Ferro, F. Field, R.D. Filipovic, N. Finco, L. Finger, M., Jr. Finger, M. Fink, S. Finkel, A. Fiore, L. Fiorendi, S. Fiori, F. Fischer, R. Fisk, I. Flacher, H. Flechl, M. Flix, J. Florent, A. Florez, C. Flouris, G. Flowers, K. Flowers, S. Flucke, G. Flügge, G. Foà, L. Focardi, E. Foerster, M. Folgueras, S. Fonseca De Souza, S. Fontaine, J.-C. Ford, W.T. Forthomme, L. Foudas, C. Fouz, M.C. Francis, B. Franco Sevilla, M. Franzoni, G. Freeman, J. Frensch, F. Friedl, M. Friese, R. Frueboes, T. Frühwirth, R. Fulcher, J. Funk, W. Furic, I.K. Futyan, D. Gadrat, S. Galanti, M. Gallinaro, M. Gallo, E. Galloni, C. Gandrajula, R.P. Ganguly, S. Ganjour, S. Garabedian, A. Garay Garcia, J. Garcia, G. Garcia-Abia, P. Garcia-Bellido, A. Garcia-Ferrero, J. Gardner, M. Garg, R.B. Garutti, E. Gary, J.W. Gascon, S. Gastler, D. Gauthier, L. Gavrilenko, M. Gavrilov, V. Gaz, A. Geenen, H. Geffert, P. Geiser, A. Geisler, M. Gelé, D. Gelli, S. Gennai, S. George, C. George, J. Geralis, T. Gerber, C.E. Gerosa, R. Gershtein, Y. Geurts, F.J.M. Ghete, V.M. Ghezzi, A. Ghosh, S. Giacomelli, P. Giakoumopoulou, V.A. Giammanco, A. Giassi, A. Giffels, M. Gigi, D. Gilbert, A. Gill, K. Gilmore, J. Giordano, D. Giordano, F. Girgis, S. Girone, M. Givernaud, A. Gizhko, A. Glege, F. Gleyzer, S.V. Glushkov, I. Gninenko, S. Go, Y. Gobbo, B. Godinovic, N. Godshalk, A. Goebel, K. Goerlach, U. Goetzmann, C. Goh, J. Gokbulut, G. Goldouzian, R. Goldstein, J. Golf, F. Golovtsov, V. Golubev, N. Golutvin, I. Gomber, B. Gomez Moreno, B. Gomez Ceballos, G. Gomez, G. Gomez, J.A. Gomez, J.P. Goncharov, M. Gonella, F. Gonzalez, D. Gonzalez Caballero, I. Gonzalez Lopez, O. Gonzalez Suarez, R. Gonzi, S. Goodell, J. Gorbunov, I. Gori, V. Görner, M. Górski, M. Gottschalk, E. Gouskos, L. Gouzevitch, M. Govoni, P. Goy Lopez, S. Gozzelino, A. Grab, C. Gran, J. Grandi, C. Granier de Cassagnac, R. Gras, P. Gray, L. Gray, R. Grebenyuk, A. Green, D. Greene, S. Gregores, E.M. Gribushin, A. Grimes, M. Grippo, M.T. Gritsan, A.V. Grothe, M. Grundler, U. Grünendahl, S. Grunewald, M. Grynyov, B. Guchait, M. Gude, A. Guida, R. Guiducci, L. Guilbaud, M. Gul, M. Guler, Y. Gulhan, D. Gülmez, E. Gundacker, S. Gunnellini, P. Gupta, R. Gurpinar, E. Gurrola, A. Gurtu, A. Gutay, L. Güth, A. Guthoff, M. Gutsche, O. Gyun, D. Haas, J. Hadjiiska, R. Hadley, N.J. Hagopian, S. Hagopian, V. Hahn, K.A. Haitz, D. Hajdu, C. Hakala, J. Halkiadakis, E. Hall, G. Hall-Wilton, R. Haller, J. Hamel de Monchenault, G. Hamer, M. Hammad, G.H. Hammer, J. Han, J. Hanlon, J. Hansen, P. Hanson, G. Hardenbrook, J. Harder, K. Hare, D. Harel, A. Härkönen, J. Harper, S. Harr, R. Harrington, C. Harris, P. Harris, R.M. Hart, A. Hartl, C. Hartmann, F. Hasegawa, S. Hassan, Q. Hatakeyama, K. Hauk, J. Hauser, J. Haytmyradov, M. Hazi, A. Heath, G.P. Heath, H.F. Hebbeker, T. Hebda, P. Hegeman, J. Heidegger, C. Heidemann, C. Heilman, J. Heindl, S.M. Heintz, U. Heister, A. Hempel, M. Henderson, C. Hensel, C. Heracleous, N. Heredia-De La Cruz, I. Hernandez, J.M. Hernandez-Almada, A. Herndon, M. Hervé, A. Hewamanage, S. Hidas, D. Hidas, P. Hildreth, M. Hill, C. Hindrichs, O. Hinzmann, A. Hirosky, R. Hirschauer, J. Hits, D. Hobson, P.R. Hoehle, F. Hoepfner, K. Hoffmann, M. Hofman, D.J. Hohlmann, M. Höing, R.S. Hollar, J. Holzner, A. Hong, B. Hoorani, H.R. Horisberger, R. Hörmann, N. Hortiangtham, A. Horvath, D. Hos, I. Hoss, J. Hou, W.-S. Hreus, T. Hrubec, J. Hsiung, Y. Hu, Z. Huang, T. Huertas Guativa, L.M. Hughes, E. Hughes, R. Hugon, J. Husemann, U. Iaselli, G. Iashvili, I. Iaydjiev, P. Ibrahim, Z.A. Ignatenko, M. Iiyama, Y. Iles, G. Ille, B. Incandela, J. Ingram, Q. Innocente, V. Innocenti, G.M. Iorio, A.O.M. Isildak, B. Ivanov, A. Ivanov, Y. Ivova PANEVA, M. Jabeen, S. Jacob, J. Jafari, A. Jain, S. Jain, S. Jandir, P. Janjam, R. Janot, P. Janssen, X. Jarry, P. Jayatilaka, B. Jeitler, M. Jensen, F. Jessop, C. Jez, P. Jha, M.K. Jha, V. Ji, W. Jiang, C.H. Jindariani, S. Jo, M. Johns, W. Johnson, A. Johnson, K.F. Johnson, M. Jones, M. Jorda, C. Josa, M.I. Joshi, U. Jung, A.W. Jung, H. Jung, K. Junkes, A. Juodagalvis, A. Kaadze, K. Kachanov, V. Kadastik, M. Kadija, K. Kaestli, H.C. Kaisen, J. Kalafut, S. Kalakhety, H. Kalinin, A. Kalinowski, A. Kalogeropoulos, A. Kalsi, A.K. Kamalieddin, R. Kamenev, A. Kaminskiy, A. Kamon, T. Kangal, E.E. Kanishchev, K. Kao, S.C. Kaplan, S. Karacheban, O. Karancsi, J. Karapinar, G. Karapostoli, G. Karchin, P.E. Kargoll, B. Karimäki, V. Karjavin, V. Karmgard, D.J. Karneyeu, A. Kasemann, M. Kasieczka, G. Katkov, I. Katsas, P. Kaur, A. Kaur, M. Kaya, M. Kaya, O. Kayis Topaksu, A. Kazana, M. Keaveney, J. Kellams, N. Keller, J. Kelley, R. Kellogg, R.G. Kennedy, E. Kenny, R.P., III Kenzie, M. Kesisoglou, S. Khachatryan, V. Khakzad, M. Khalil, S. Khan, A. Khan, W.A. Kharchilava, A. Khatiwada, A. Khristenko, V. Khukhunaishvili, A. Khurana, R. Khurshid, T. Kiani, B. Kiesel, M.K. Kieseler, J. Kilminster, B. Kim, D. Kim, D.H. Kim, G.N. Kim, H. Kim, H. Kim, H. Kim, J.H. Kim, M.S. Kim, T.J. Kim, V. Kim, Y. Kinnunen, R. Kirakosyan, M. Kirsanov, M. Kirschenmann, H. Klabbers, P. Klanner, R. Klapoetke, K. Klein, D. Klein, K. Kleinwort, C. Klima, B. Klute, M. Knowlton, D. Knünz, V. Knutsson, A. Knutzen, S. Ko, W. Koay, S.A. Kodolova, O. Kogler, R. Kokkas, P. Kolberg, T. Kole, G. Komaragiri, J.R. Komm, M. Konecki, M. Kong, D.J. König, A. Konigsberg, J. Konoplyanikov, V. Konstantinov, D. Konyushikhin, M. Kornmayer, A. Korol, I. Korotkikh, V. Kortelainen, M.J. Korytov, A. Kothekar, K. Kotlinski, D. Kotov, K. Kottachchi Kankanamge Don, C. Kousouris, K. Kovac, M. Kovalchuk, N. Kovalskyi, D. Kovitanggoon, K. Krajczar, K. Krammer, M. Krasnikov, N. Krätschmer, I. Kravchenko, I. Kreczko, L. Kreis, B. Kress, T. Kreuzer, P. Krofcheck, D. Krohn, M. Krolikowski, J. Kropivnitskaya, A. Krutelyov, V. Krychkine, V. Kubik, A. Kubota, Y. Kuessel, Y. Kumar, A. Kumar, A. Kumar, A. Kumar, A. Kumar, R. Kumar, S. Kumar, V. Kunkle, J. Kunnawalkam Elayavalli, R. Kunori, S. Künsken, A. Kuo, C.M. Kurt, P. Kuznetsova, E. Kwan, S. Kwon, E. Kyberd, P. Kyriakis, A. La Licata, C. Lacroix, F. Lagarde, F. Lai, Y.S. Laird, E. Laktineh, I.B. Lamichhane, K. Lamichhane, P. Lammel, S. Lampén, T. Lanaro, A. Lander, R. Landsberg, G. Lane, R. Lanev, A. Lange, C. Lange, D. Lange, W. Langenegger, U. Lannon, K. Lanza, G. Lapsien, T. Lariccia, P. Lassila-Perini, K. Lath, A. Lauwers, J. Lawson, P. Le Bihan, A.-C. Lecoq, P. Ledovskoy, A. Lee, B. Lee, J. Lee, J.S.H. Lee, K. Lee, K.S. Lee, S. Lee, S. Lee, S.W. Lee, Y.-J. Leggat, D. Lehti, S. Lelas, D. Lemaitre, V. Lenz, T. Lenzi, P. Lenzi, T. Léonard, A. Leonard, J. Leonardo, N. Leonidov, A. Lesko, Z. Leslie, D. Lethuillier, M. Letts, J. Levchenko, P. Levchuk, L. Levin, A. Levine, A. Li, H. Li, Q. Li, W. Libeiro, T. Ligabue, F. Liko, D. Lin, C. Lin, W. Linacre, J. Lincoln, D. Lindén, T. Ling, T.Y. Lingemann, J. Linn, S. Lipinski, M. Lipka, K. Lipton, R. Lisniak, S. Lista, L. Litov, L. Liu, B. Liu, H. Liu, S. Liu, T. Liu, Y.F. Lloret Iglesias, L. Lo Vetere, M. Lobanov, A. Lobelle Pardo, P. Locci, E. Lohmann, W. Lokhtin, I. Lomtadze, T. Long, K. Long, O.R. Longo, E. Lopes De Sá, R. Lopez Virto, A. Lopez-Fernandez, R. Loukas, D. Loukas, N. Lourenço, C. Loveless, R. Low, J.F. Lowette, S. Lu, R.-S. Lu, Y. Lu, Y.J. Lucas, C. Lucas, R. Lucchini, M.T. Luckey, P.D. Luetic, J. Lujan, P. Luo, W. Lustermann, W. Luthra, A. Luukka, P. Luyckx, S. Lychkovskaya, N. Lykken, J. Lyons, L. Ma, P. Machet, M. Macneill, I. Mäenpää, T. Maerschalk, T. Maeshima, K. Maggi, G. Maggi, M. Magini, N. Magnan, A.-M. Magnani, A. Maguire, C. Mahakud, B. Mahrous, A. Maier, B. Maity, M. Majumdar, N. Majumder, D. Majumder, G. Makouski, M. Makovec, A. Maksimovic, P. Mal, P. Malakhov, A. Malberti, M. Malbouisson, H. Malcles, J. Malek, M. Malgeri, L. Malhotra, S. Malik, S. Malik, S. Malvezzi, S. Mandal, K. Mangano, B. Mankel, R. Mannelli, M. Mans, J. Manthos, N. Mantovani, G. Manzoni, R.A. Mao, Y. Mao, Y. Mao, Z. Maravin, Y. Marcellini, S. Marchesini, I. Marco, J. Marco, R. Marconi, D. Marfin, I. Margaroli, F. Margoni, M. Marinelli, N. Marini, A.C. Marinov, A. Marionneau, M. Mariotti, C. Markowitz, P. Marlow, D. Maron, G. Marone, M. Marraffino, J.M. Martelli, A. Martin, C. Martinez Rivero, C. Martinez, G. Martinez Ruiz del Arbol, P. Martinez Outschoorn, V.I. Martini, L. Maruyama, S. Marzocchi, B. Masciovecchio, M. Maselli, S. Masetti, G. Masetti, L. Mason, D. Massironi, A. Mastrolorenzo, L. Matchev, K. Matorras, F. Matos Figueiredo, D. Matsushita, T. Matveev, V. Mavromanolakis, G. Mazumdar, K. McBride, P. Mccartin, J. Mccoll, N. Mcginn, C. Md Ali, M.A.B. Medvedeva, T. Mehta, A. Mei, H. Meier, F. Meijers, F. Meister, D. Melo, A. Melzer-Pellmann, I.-A. Menasce, D. Meneguzzo, A.T. Meng, F. Meng, Z. Menichelli, M. Meola, S. Mercadante, P.G. Meridiani, P. Merkel, P. Merlin, J.A. Merlo, J.-P. Mermerkaya, H. Merola, M. Merschmeyer, M. Mersi, S. Mertens, A. Meschi, E. Meschini, M. Messineo, A. Mestvirishvili, A. Mesyats, G. Meyer, A. Meyer, A.B. Meyer, M. Miñano Moya, M. Micanovic, S. Micheli, F. Michelotto, M. Michlin, B. Migliore, E. Mignerey, A.C. Mikulec, I. Mildner, H. Milenovic, P. Miller, D.H. Millet, P. Milosevic, J. Miné, P. Miniello, G. Mirabito, L. Mirman, N. Mironov, C. Mishra, K. Misiura, M. Missiroli, M. Mitra, S. Mitselmakher, G. Mittag, G. Mittal, M. Mnich, J. Modak, A. Moeller, A. Mohamad Idris, F. Mohammadi, A. Mohammadi Najafabadi, M. Mohanty, A.K. Mohanty, G.B. Mohapatra, A. Moisenz, P. Molnar, J. Monaco, V. Mondal, K. Monge, M.R. Monroy, J. Montagna, P. Montanari, A. Montecassiano, F. Monteil, E. Moon, C.S. Mooney, M. Moortgat, F. Mora Herrera, C. Moraes, A. Moran, D. Moreels, L. Morelos Pineda, A. Moroni, L. Morovic, S. Morse, D.M. Mossolov, V. Mott, A. Mousa, J. Mozer, M.U. Mrenna, S. Mucia, N. Mueller, C. Mueller, R. Mukherjee, S. Mukhopadhyay, S. Mulders, M. Mulhearn, M. Mulholland, T. Müller, T. Müller, T. Mullin, S.D. Mundim, L. Murray, M. Murumaa, M. Murzin, V. Musella, P. Musich, M. Musienko, Y. Mussgiller, A. My, S. Myagkov, I. Nachtman, J. Nahn, S. Naimuddin, M. Nam, S.K. Narain, M. Naranjo, I.N. Narayanan, S. Naseri, M. Nash, D. Nash, J. Nash, K. Nauenberg, U. Naumann-Emme, S. Navarria, F.L. Navarro De Martino, E. Nawrocki, K. Nayak, A. Nehrkorn, A. Nemallapudi, M.V. Nessi-Tedaldi, F. Neu, C. Neugebauer, H. Neumeister, N. Newbold, D.M. Newman, H.B. Newman-Holmes, C. Ngadiuba, J. Nguyen, F. Nguyen, M. Ni, H. Nicolaou, C. Nicolas Kaufman, G. Nikitenko, A. Nishu, N. Niu, X. Nogima, H. Noonan, D. Northup, M. Nourbakhsh, S. Novaes, S.F. Nowack, A. Nowatschin, D. Ntomari, E. Nugent, I.M. Nuttens, C. Nuzzo, S. O'Brien, C. O'Dell, V. Obertino, M.M. Obraztsov, S. Ocampo Rios, A.A. Ochando, C. Odell, N. Ogul, H. Oh, Y.D. Ojalvo, I. Olaiya, E. Olbrechts, A. Oliveros, S. Olivito, D. Olmedo Negrete, M. Olschewski, M. Olsen, J. Olszewski, M. Onel, Y. Onengut, G. Oreshkin, V. Orfanelli, S. Organtini, G. Orimoto, T. Orsini, L. Ortona, G. Osherson, M. Osipenkov, I. Ostapchuk, A. Ott, J. Ozdemir, K. Ozok, F. Ozturk, S. Pacher, L. Padeken, K. Padhi, S. Padley, B.P. Paganini, P. Paganoni, M. Pakhotin, Y. Paktinat Mehdiabadi, S. Palencia Cortezon, E. Palichik, V. Palla, F. Palmer, C. Panagiotou, A. Pandolfi, F. Pant, L.M. Pantaleo, F. Panwalkar, S. Paoletti, S. Paolucci, P. Papacz, P. Papadopoulos, I. Pape, L. Paradas, E. Paramatti, R. Paramesvaran, S. Parashar, N. Parida, B. Park, I.C. Park, M. Park, S.K. Pashenkov, A. Passaseo, M. Pastika, N. Pastrone, N. Pata, J. Patel, R. Patterson, J.R. Paulini, M. Paus, C. Pauss, F. Pavlov, B. Pazzini, J. Pedraza, I. Pedrini, D. Pedro, K. Pegoraro, M. Peiffer, T. Pekkanen, J. Pela, J. Pellett, D. Pelliccioni, M. Peltola, T. Pena, C. Penzo, A. Pequegnot, A.L. Perelygin, V. Perez, E. Pérez-Calero Yzquierdo, A. Perieanu, A. Perloff, A. Perniè, L. Perrey, H. Perries, S. Perrini, L. Perrotta, A. Perrozzi, L. Perry, T. Peruzzi, M. Pesaresi, M. Petkov, P. Petrakou, E. Petridis, K. Petrilli, A. Petrillo, G. Petrov, V. Petrucciani, G. Petrushanko, S. Petyt, D. Pfeiffer, A. Piccolo, D. Piedra Gomez, J. Pieri, M. Pierini, M. Pierro, G.A. Pietsch, N. Pigard, P. Pilot, J. Pin, A. Pinna, D. Pinna Angioni, G.L. Piotrzkowski, K. Piparo, D. Piperov, S. Piroué, P. Pistone, C. Pitzl, D. Placakyte, R. Plagge, M. Planer, M. Plestina, R. Poehlsen, J. Pol, M.E. Polese, G. Poll, A. Pollack, B. Pompili, A. Pook, T. Pooth, O. Popov, A. Popov, V. Potenza, R. Poyraz, D. Pozdnyakov, A. Pozdnyakov, I. Pozzobon, N. Prado Da Silva, W.L. Preiato, F. Preuten, M. Primavera, F. Prokofyev, O. Prosper, H. Psallidas, A. Ptochos, F. Puerta Pelayo, J. Pugliese, G. Puigh, D. Puljak, I. Python, Q. Qian, S.J. Quast, G. Quertenmont, L. Quintario Olmeda, A. Quittnat, M. Yates, B.R. Rabady, D. Rabbertz, K. Racz, A. Radburn-Smith, B.C. Radi, A. Radogna, R. Radziej, M. Ragazzi, S. Rahatlou, S. Rahbaran, B. Raics, P. Raidal, M. Rakness, G. Ralph, D. Rander, J. Randle-conde, A. Ranieri, A. Ranjan, K. Rank, D. Rankin, D. Rappoccio, S. Raspereza, A. Rathjens, D. Ratnikov, F. Ratti, S.P. Raupach, F. Ravera, F. Raymond, D.M. Razis, P.A. Re, V. Rebassoo, F. Rebello Teles, P. Redaelli, N. Redjimi, R. Redondo, I. Regnard, S. Reid, I.D. Reinsvold, A. Reis, T. Reithler, H. Rekovic, V. Renker, D. Rezaei Hosseinabadi, F. Ribeiro Cipriano, P.M. Riccardi, C. Ricci-Tam, F. Richards, A. Richardson, C. Richman, J. Rieger, M. Riley, G. Rinkevicius, A. Rizzi, A. Roberts, J. Robmann, P. Robutti, E. Röcker, S. Rodenburg, M. Rodozov, M. Rodrigo, T. Rodrigues Antunes, J. Rodriguez, J.L. Rodríguez-Marrero, A.Y. Roh, Y. Rohe, T. Rohlf, J. Rohringer, H. Roland, B. Roland, C. Roland, G. Rolandi, G. Romanowska-Rybinska, K. Romeo, F. Romero, A. Romero Abad, D. Romero, L. Ronchese, P. Ronga, F.J. Roozbahani, B. Rorie, J. Roscher, F. Rose, A. Rose, A. Rose, K. Roskes, J. Rosowsky, A. Rossi, A.M. Rossin, R. Rossini, M. Rovelli, C. Rovelli, T. Rovere, M. Roy, A. Roy, D. Roy Chowdhury, S. Roy, T. Ruan, M. Ruchti, R. Ruckstuhl, N. Ruggles, T. Ruiz Vargas, J.C. Ruiz Alvarez, J.D. Ruiz-Jimeno, A. Rumerio, P. Rusack, R. Rusakov, S.V. Ruspa, M. Russ, J. Ryckbosch, D. Ryd, A. Rykaczewski, H. Ryu, G. Ryu, M.S. Ryutin, R. Padula, S.S. Sabes, D. Sacchi, R. Sady, A. Safarzadeh, B. Safonov, A. Safronov, G. Sagir, S. Saha, A. Sahin, M.Ö. Sahoo, D.K. Sahoo, N. Saini, L.K. Saka, H. Sakharov, A. Sakulin, H. Sakuma, T. Salazar Ibarguen, H.A. Salerno, D. Salerno, R. Salfeld-Nebgen, J. Saltzberg, D. Salur, S. Salva, S. Salvini, P. Sanabria, J.C. Sanchez-Hernandez, A. Sander, C. Sanders, S. Sandoval Gonzalez, I.D. Sani, M. Santanastasio, F. Santaolalla, J. Santocchia, A. Santoro, A. Saoulidou, N. Sarangi, T. Sarica, U. Sarkar, S. Sarkar, T. Sauvan, J.B. Savin, A. Savoy-Navarro, A. Savrin, V. Saxena, P. Schael, S. Schäfer, C. Scharf, C. Schettler, H. Scheuch, F. Schieck, J. Schizzi, A. Schleper, P. Schlieckau, E. Schmidt, A. Schmitt, M. Schnetzer, S. Schoerner-Sadenius, T. Schöfbeck, R. Schröder, M. Schulte, J.F. Schwandt, J. Schwick, C. Sciacca, C. Scodellaro, L. Seez, C. Seidel, M. Seif El Nasr-storey, S. Seitz, C. Seixas, J. Selvaggi, G. Selvaggi, M. Sen, S. Senkin, S. Serban, A.T. Seva, T. Sexton-Kennedy, E. Sgandurra, L. Sguazzoni, G. Shaheen, S.M. Shalhout, S. Sharan, M. Sharma, A. Sharma, A. Sharma, R. Sharma, S. Sharma, V. Sharma, V. Shchutska, L. Sheffield, D. Sheldon, P. Shepherd-Themistocleous, C.H. Shi, X. Shin, Y.H. Shipsey, I. Shmatov, S. Shoaib, M. Shrinivas, A. Shukla, P. Shulha, S. Shumeiko, N. Siado, J.E. Sieber, G. Sigamani, M. Sikler, F. Silkworth, C. Silva, P. Silvers, D. Silvestris, L. Simon, M. Simon, S. Simonetto, F. Simonis, H.J. Singh, G. Singh, J.B. Sinthuprasith, T. Sirois, Y. Siroli, G.P. Sirunyan, A.M. Skatchkov, N. Skhirtladze, N. Skinnari, L. Skovpen, K. Skuja, A. Smirnov, I. Smirnov, V. Smith, D. Smith, G. Smith, J. Smith, N. Smith, V.J. Smith, W.H. Snigirev, A. Snook, B. Snow, G.R. Snowball, M. Snyder, C. Soares, M.S. Sobol, A. Soffi, L. Soha, A. Sola, V. Solano, A. Somalwar, S. Son, D.C. Song, S. Sonnenschein, L. Sordini, V. Sorokin, P. Spagnolo, P. Spalding, W.J. Spanier, S. Spannagel, S. Sperka, D. Sphicas, P. Spiegel, L. Spiezia, A. Spiridonov, A. Spiropulu, M. Squires, M. Srimanobhas, N. St. John, J. Stadie, H. Stahl, A. Staiano, A. Starodumov, A. Steggemann, J. Steinbrück, G. Stenson, K. Stephans, G.S.F. Stickland, D. Stieger, B. Stober, F.M. Stolp, D. Stone, R. Stoye, M. Stoykova, S. Stoynev, S. Strauss, J. Strebler, T. Stringer, R. Strobbe, N. Strologas, J. Strom, D. Stuart, D. Stupak, J. Sturdy, J. Suarez, I. Suarez Gonzalez, J. Sudic, L. Sulak, L. Sulimov, V. Sultanov, G. Sumorok, K. Sun, J. Sun, M. Sun, W. Sun, X. Sung, K. Sur, N. Sutar, B. Suwonjandee, N. Svyatkovskiy, A. Swain, S.K. Swartz, M. Syarif, R. Symonds, P. Szillasi, Z. Szleper, M. Sznajder, A. Tabarelli de Fatis, T. Tadel, M. Takahashi, M. Takahashi, Y. Takasugi, E. Tali, B. Talvitie, J. Tambe, N. Tan, P. Tan, S.M. Tao, J. Tapper, A. Taroni, S. Tatarinov, A. Tavernier, S. Tavolaro, V.R. Taylor, D. Taylor, L. Teixeira De Lima, R. Tenchini, R. Teo, W.D. Teodorescu, L. Terentyev, N. Teyssier, D. Thea, A. Theofilatos, K. Tholen, H. Thom, J. Thomas, L. Thomas, S. Thomassen, P. Thompson, J. Thüer, S. Thyssen, F. Tiko, A. Tiras, E. Titov, M. Tkaczyk, S. Tlisov, D. Toda, S. Toldaiev, O. Tomalin, I.R. Tonelli Manganote, E.J. Tonelli, G. Tonjes, M.B. Tonwar, S.C. Topakli, H. Topkar, A. Topsis-Giotis, I. Torassa, E. Toriashvili, T. Toropin, A. Tosi, M. Tosi, N. Tosi, S. Tourtchanovitch, L. Traczyk, P. Tran, N.V. Trauger, H. Travaglini, R. Treberer-Treberspurg, W. Treille, D. Trevisani, N. Tricomi, A. Triossi, A. Tripathi, M. Trippkewitz, K.D. Trocino, D. Trocsanyi, Z.L. Troendle, D. Tropiano, A. Troshin, S. Trovato, M. Tsai, J.F. Tsamalaidze, Z. Tsirou, A. Tu, Z. Tucker, J. Tully, C. Tumasyan, A. Tuo, S. Tuominen, E. Tuominiemi, J. Tuovinen, E. Turkewitz, J. Turner, M. Turner, P. Tuuva, T. Tuve, C. Tytgat, M. Tyurin, N. Tzeng, Y.M. Tziaferi, E. Bhawandeep, U. Uchida, K. Ujvari, B. Ulmer, K.A. Ulrich, R. Undleeb, S. Uplegger, L. Usai, E. Uvarov, L. Uzunian, A. Vaandering, E.W. Vadruccio, D. Vai, I. Vaitkus, J. Valls, N. Valuev, V. Van Spilbeeck, A. Van Onsem, G.P. Van Haevermaet, H. Van Parijs, I. Van De Klundert, M. Van Remortel, N. Van Mulders, P. Van Mechelen, P. Van Hove, P. Van Doninck, W. Van Driessche, W. Vander Velde, C. Vander Donckt, M. Vanelderen, L. Vanhoefer, A. Vanini, S. Vanlaer, P. Vardanyan, I. Vardarlı, F.I. Varela, J. Varelas, N. Varma, M. Vartak, A. Vavilov, S. Vazquez Valencia, F. Vazquez Acosta, M. Veelken, C. Velasco, M. Velicanu, D. Velkovska, J. Venditti, R. Ventura, S. Venturi, A. Verdier, P. Verdini, P.G. Veres, G.I. Vergili, M. Verlage, T. Vernieri, C. Verwilligen, P. Verzetti, M. Verzocchi, M. Veszpremi, V. Vesztergombi, G. Veverka, J. Vidal Marono, M. Vidal, R. Vila, I. Vilar Cortabitarte, R. Vilela Pereira, A. Viliani, L. Virdee, T. Viret, S. Vischia, P. Vitulo, P. Vizan Garcia, J.M. Vlasov, E. Vlimant, J.R. Vogel, H. Volkov, A. Volobouev, I. Vormwald, B. Vorobiev, I. Vorobyev, A. Voutilainen, M. Vutova, M. Wagner, S.R. Wagner-Kuhr, J. Walczak, M. Walia, G. Walker, M. Wallny, R. Walsh, R. Waltenberger, W. Wan Abdullah, W.A.T. Wang, C. Wang, D. Wang, F. Wang, J. Wang, J. Wang, Q. Wang, R.-J. Wang, S. Wang, T.W. Wang, Y. Wang, Z. Wardle, N. Wasserbaech, S. Wayand, S. Wayne, M. Weber, H. Weber, H.A. Weber, M. Weber, M. Wei, H. Weiler, T. Weinberg, M. Welke, C. Wendland, L. Weng, Y. West, C. Wetzel, J. Whitbeck, A. Wickramage, N. Wilbur, S. Williams, T. Wimpenny, S. Winer, B.L. Wissing, C. Wittich, P. Wittmer, B. Wöhri, H.K. Wöhrmann, C. Wolf, M. Wolf, R. Wolfe, E. Wood, D. Wood, J. Woodard, A. Woods, N. Worm, S.D. Wright, D. Wu, Z. Wulsin, H.W. Wulz, C.-E. Würthwein, F. Wyslouch, B. Xia, F. Xiao, M. Xie, S. Xie, W. Xin, Y. Xu, L. Xu, Q. Xu, Z. Yagil, A. Yalvac, M. Yang, F. Yang, M. Yang, Y. Yazgan, E. Yelton, J. Yetkin, E.A. Yetkin, T. Yi, K. Yilmaz, Y. Yohay, R. Yonamine, R. Yoo, H.D. Yoo, J. York, A. You, C. Yu, I. Yu, S.S. Yumiceva, F. Yusli, M.N. Zabel, J. Zabi, A. Zaganidis, N. Zagozdzinska, A. Zakaria, M. Zalewski, P. Zanetti, A. Zanetti, M. Zarubin, A. Zeinali, M. Zenoni, F. Zenz, S.C. Zeuner, W.D. Zevi Della Porta, G. Zeyrek, M. Zghiche, A. Zhang, F. Zhang, H. Zhang, J. Zhokin, A. Zhu, R.Y. Zhukov, V. Zhukova, V. Zorbilmez, C. Zotto, P. Zou, D. Zsigmond, A.J. Zucchetta, A. Zuranski, A. d'Enterria, D. de Trocóniz, J.F. de Barbaro, P. du Pree, T. CMS Collaboration
- Published
- 2016
39. Ultrafast Optical Control of the Electronic Properties of ZrTe₅
- Author
-
G, Manzoni, A, Sterzi, A, Crepaldi, M, Diego, F, Cilento, M, Zacchigna, Ph, Bugnon, H, Berger, A, Magrez, M, Grioni, and F, Parmigiani
- Abstract
We report on the temperature dependence of the ZrTe(5) electronic properties, studied at equilibrium and out of equilibrium, by means of time and angle resolved photoelectron spectroscopy. Our results unveil the dependence of the electronic band structure across the Fermi energy on the sample temperature. This finding is regarded as the dominant mechanism responsible for the anomalous resistivity observed at T*∼160 K along with the change of the charge carrier character from holelike to electronlike. Having addressed these long-lasting questions, we prove the possibility to control, at the ultrashort time scale, both the binding energy and the quasiparticle lifetime of the valence band. These experimental evidences pave the way for optically controlling the thermoelectric and magnetoelectric transport properties of ZrTe(5).
- Published
- 2015
40. [Untitled]
- Author
-
G. Manzoni, Benedetta Marmiroli, and R. Frassine
- Subjects
Propellant ,Pyrotechnic composition ,animal structures ,Materials science ,Potassium perchlorate ,Mechanical Engineering ,Composite number ,macromolecular substances ,Condensed Matter Physics ,Thermal conductivity measurement ,chemistry.chemical_compound ,Thermal conductivity ,chemistry ,Mechanics of Materials ,Pyrotechnic initiator ,General Materials Science ,Composite material ,Porosity - Abstract
A Miniaturised Pyrotechnic Initiator (MPI) is a device used to ignite a charge. It is reduced in scale in order to be suitable for application in miniaturised satellites. Miniaturising the system presents challenges requiring careful consideration of propellant selection. Thermal conductivity tests have been conducted on different mixtures of composite solid propellant materials in order to determine the thermal conductivity of the propellant in the temperature range 0-100 °C and to study the effect of the presence of porosity and bubbles on the thermal conductivity of the propellant. The applicability of semiempirical Ziebland Relation to predict the thermal conductivity of the composite propellant once the values of the single components are known has been assessed. Furthermore, mixtures of Al and Potassium Perchlorate powders with different compression factors have been examined in order to understand the influence of the processing conditions on thermal conductivity
- Published
- 2003
- Full Text
- View/download PDF
41. Surface topography of Dome Concordia (Antarctica) from kinematic interferential GPS and bedrock topography
- Author
-
Alessandro Capra, Ignazio E. Tabacco, G. Manzoni, Stefano Gandolfi, Raffaela Cefalo, and Luca Vittuari
- Subjects
Surface (mathematics) ,010506 paleontology ,geography ,geography.geographical_feature_category ,010504 meteorology & atmospheric sciences ,business.industry ,Bedrock ,Kinematics ,Geodesy ,01 natural sciences ,Kinematic GPS Topography DOMeC Antarctica Glaciology ,Dome (geology) ,Global Positioning System ,business ,Geomorphology ,Geology ,0105 earth and related environmental sciences ,Earth-Surface Processes - Abstract
A new plano-altimetric map of the Dome Concordia (Dome C) area was drawn up from 1995/96 kinematic double-frequency global-positioning-system (GPS) data of two different projects, as well as static GPS data from a geodetic net for deformation analysis and ice-flow velocity measurements covering an area of about 2000 km2.The GPS surveys were carried out for EPICA during the 10th and 11th Italian Expeditions to choose the optimal location for deep ice-core drilling at Dome C. The accuracy of the kinematic survey was tested by analysing the height-value differences at intersections between different profiles; values ranged from 50–150 mm.The new map was compared with the 1993 kinematic interferential GPS data and residuals between the 1993 and 1995 data were calculated. The surface topographic values were used to calculate the elevation of the Dome C area bedrock, obtained from the reference ground-based and airborne radio-echo-sounding surveys.
- Published
- 2000
- Full Text
- View/download PDF
42. Microthrusters and Microturbines Technologies and Prototypes: a Roadmap for Nanosatellites Propulsion and Power
- Author
-
G. Manzoni, S. Matsumoto, R. Maeda, TORTORA, PAOLO, G. Manzoni, P. Tortora, S. Matsumoto, and R. Maeda
- Subjects
MICROSATELLITES ,MICROPROPULSION ,MICROTHRUSTERS ,ALMASAT ,SPACE TECHNOLOGIES - Abstract
The requirements for micropropulsion systems on nano and micro satellites have been analyzed and a detailed building block list has been proposed. The Technology Readiness Level (TRL) of the necessary subgroups and components like micronozzle, microturbines or microvalves has been assessed based on literature and components available on the market. A Cold-Gas microthruster capable of thrust in the range of 100 microN to 1 mN have been designed and prototyped. An application of such Cold-Gas system will be described for the microsatellite (ALMASAT) developed by the University of Bologna. A Microturbine prototype in course of development and capable of few Watt of power will be presented and the related technology and application potential will be discussed. International roadmaps will be presented and updated in relation to an optimized benefit/effort development path.
- Published
- 2004
43. La UPSA y el patrimonio cultural de la nación: Hacienda 'KANTU ÑUCCHU' (Sucre)
- Author
-
Mauricio Elío G. Manzoni
- Abstract
Aún pediré otro premio a la Nación entera y a sus administradores. El de no destruir la obra de mi creación y de conservar por sobre todos los peligros la independencia de Bolivia.Mariscal Sucre , 1828
- Published
- 1995
- Full Text
- View/download PDF
44. Objeto alfa: Una forma de hacer cultura... Un medio de comunicación... Una transformación para el cambio... Un aporte al desarrollo
- Author
-
Mauricio Elio G. Manzoni
- Abstract
Atrévete a soñar... visualiza en tu mente lo que más quieras. Deja que tus sentimientos lo envuelvan todo y materializa tu idea en un objeto... el mismo será un reflejo de tu esencia y mediante él podrás comunicarte con el mundo. Fortaleciendo así tu propia identidad podrás contribuir al desarrollo de la Supra Cultura Universal.Mauricio Ello Gabriel Manzon.
- Published
- 1994
- Full Text
- View/download PDF
45. Dome C (Antarctica) Topography by Means of Kinematic Interferential GPS and Bedrock Topography
- Author
-
A. CAPRA, S. GANDOLFI, G. MANZONI, I. E. TABACCO, L. VITTUARI, CEFALO, RAFFAELA, A., Capra, Cefalo, Raffaela, S., Gandolfi, G., Manzoni, I. E., Tabacco, and L., Vittuari
- Published
- 2000
46. Virtual vineyard for grapevine management purposes: A RFID/GPS application
- Author
-
R. Bandinelli, Andrea Luvisi, Mario Pagano, Mario Scartòn, Enrico Triolo, Barbara Gini, E. Rinaldelli, G. Manzoni, Luvisi, Andrea, Pagano, Mario, Bandinelli, Roberto, Rinaldelli, Enrico, Gini, Barbara, Scartòn, Mario, Manzoni, Giorgio, and Triolo, Enrico
- Subjects
Geographic information system ,Database ,Traceability ,Computer science ,business.industry ,Forestry ,Horticulture ,computer.software_genre ,Vineyard ,Computer Science Applications ,Software ,Assisted GPS ,Global Positioning System ,Geographic coordinate system ,business ,Telecommunications ,Agronomy and Crop Science ,computer - Abstract
A method for combining data stored in an RFID microchip implanted inside grapevine plants and a GPS system is described. GIS software was used to register geographic coordinates of detected points, and to develop a specific database in which information useful for the positioning phase are stored. The final product is a digital map accessible via mobile or desktop systems that represents the ''virtual vineyard''. In this digital representation, each grapevine plant marked by RFID can be selected, viewed and edited. Free-to-use software was implemented for use by consumers.
- Published
- 2011
47. Functional living skills assessment: a standardized measure of high-order activities of daily living in patients with dementia
- Author
-
E, Farina, R, Fioravanti, R, Pignatti, M, Alberoni, F, Mantovani, G, Manzoni, L, Chiavari, E, Imbornone, F, Villanelli, and R, Nemni
- Subjects
Aged, 80 and over ,Male ,Disability Evaluation ,Activities of Daily Living ,Humans ,Dementia ,Female ,Middle Aged ,Aged - Abstract
Performance measures are tools aimed to directly evaluate social function in older adults. The authors present the standardization of a new direct performance measure for patients with dementia, the functional living skills assessment (FLSA).FLSA was conceived to detect functional impairment in very mild to moderate patients and to pick up functional modification due to intervention. The patient is asked to perform an activity, and the performance is scored according to completeness and level of assistance required. Eight areas of interest are evaluated (Resources, Consumer Skills, Public Transportation, Time Management, Money management, Leisure, Telephone Skills, Self-Care and Health). Subjects included 54 patients with dementia and 36 normal controls.Total and partial FLSA scores significantly differed for the two groups (P0.0001). Performance on FLSA could divide clinical dementia rating (CDR) 0 from CDR 1, CDR 2 e CDR 3 groups. Both sensitivity and specificity were 94%; inter-rater and test-retest reliability was good (P0.9). Correction scores for education were calculated, while age influence was only marginally significant. Mini Mental State Examination (MMSE) and CDR highly influenced FLSA score (P0.0001); FLSA was highly correlated with another performance measure (the Direct Assessment of Functional Status; P=0.821), and with the Instrumental Activity of Daily Living (IADL) scale (P=-0.612), while no significant correlation was present with the Geriatric Depression Scale.FLSA evidences construct, concurrent and discriminative validity. We suggest that this tool could be possibly useful when a high sensibility to different levels of functional impairment is needed, as evaluation of treatment efficacy (both non-pharmacological and pharmacological) identification of relatively intact functional areas to plan cognitive rehabilitation, and confirmation of dementia in the initial phase when there are doubts about functional decline.
- Published
- 2010
48. Genetic variability in rDNA ITS region of Trichoderma spp. (biocontrole agent) and Fusarium oxysporum f. sp. chrysanthemi isolates
- Author
-
Clarice G. Manzoni, Elena Blume, Manoeli Lupatini, Zaida Inês Antoniolli, Emanuele Junges, and Josiane Pacheco Menezes
- Subjects
General Veterinary ,Soilborne fungi ,Soil Science ,análises de DNA ,Biology ,Dna amplification ,Genetic analysis ,Molecular biology ,endonucleases ,law.invention ,molecular characterization ,law ,Genetic marker ,sequences ,Animal Science and Zoology ,Natural enemies ,DNA analysis ,sequências ,Fungos de solo ,Agronomy and Crop Science ,Polymerase chain reaction ,caracterização molecular ,Food Science - Abstract
A análise de características morfológicas e culturais podem não ser suficientes para uma caracterização precisa das espécies de Trichoderma e Fusarium. Objetivou-se, neste trabalho, caracterizar a região do Espaço Interno Transcrito (ITS) do rDNA dos isolados UFSMT15.1, UFSMT16 e UFSMT17 de Trichoderma spp. utilizados no biocontrole de Fusarium oxysporum f. sp. chrysanthemi (isolado) UFSMF6. A extração de DNA de cada isolado foi realizada a partir de micélio produzido em meio líquido Batata-Dextrose. As amostras de DNA genômico foram submetidas à Reação em Cadeia da Polimerase (PCR) com os oligonucleotídeos iniciadores universais ITS1 e ITS4 e o produto gerado foi sequenciado. Os fragmentos gerados pela amplificação da PCR foram tratados com as enzimas de restrição HaeIII, HinfI e MboI. As regiões ITS1, ITS2 e 5.8S do rDNA desses isolados fúngicos foram amplificadas com sucesso. A região ITS dos isolados UFSMT15.1, UFSMT16 e UFSMT17 de Trichoderma e o isolado UFSMF6 de Fusarium apresentaram uma banda simples com um fragmento de aproximadamente 600 pares de base (pb). As enzimas de restrição HaeIII, HinfI e MboI geraram polimorfismo de bandas entre os isolados. Com base nas análises da sequência de DNA, os isolados UFSMT15.1, UFSMT16, UFSMT17 e UFSMF6 apresentaram maior similaridade com as espécies Trichoderma koningiopsis, Hypocrea virens, Hypocrea lixii e Fusarium oxysporum, respectivamente. The analysis of morphological and cultural characteristics may not enough for the characterization of the species of Trichoderma and Fusarium. The aim of this work was to characterize the Internal Transcribed Spacer (ITS) region of the rDNA of UFSMT15.1, UFSMT16 and UFSMT17 isolates of Trichoderma spp. used in the biocontrol of Fusarium oxysporum f. sp. chrysanthemi UFSMF6. DNA extraction of each isolate was accomplished starting from hyphae produced in liquid medium Potato-Dextrose-Agar. The samples of genomic DNA were submitted to the Polymerase Chain Reaction (PCR) with the primers ITS1 and ITS4, and the product was sequenced. The fragments generated from PCR amplification were digested with the restriction enzymes HaeIII, HinfI and MboI. The ITS region of the Trichoderma's isolates UFSMT15.1, UFSMT16 and UFSMT17 and the Fusarium UFSMF6 isolate showed a simple band with a fragment with 600 base pairs (bp) approximately. The restriction enzymes HaeIII, HinfI and MboI generated band polymorphism among the isolates. The isolates UFSMT15.1, UFSMT16, UFSMT17 and UFSMF6 showed high similarity whit Trichoderma koningiopsis, Hypocrea virens, Hypocrea lixii and Fusarium oxysporum species, respectively.
- Published
- 2010
49. New aryltellurenyl iodides with uncommon valences: synthetic and structural characteristics of [RTeTeI(2)R], [R(2)TeTeR(2)][Te(4)I(14)], and [RTe(I)I(2)] (R = 2,6-dimethoxyphenyl)
- Author
-
G. Manzoni De Oliveira, Eliandro Faoro, and E. Schulz Lang
- Subjects
Inorganic Chemistry ,chemistry.chemical_classification ,chemistry ,Oxidation state ,Stereochemistry ,Reagent ,Cationic polymerization ,chemistry.chemical_element ,Physical and Theoretical Chemistry ,Counterion ,Tellurium ,Iodine ,Medicinal chemistry - Abstract
(RTe) 2 (R = 2,6-dimethoxyphenyl) reacted with iodine to give [RTeTel 2 R] (1), [R 2 TeTeR 2 ][Te 4 I 14 ] (2), and [RTe(I)I 2 ] (3). The synthesis of the mixed-valent, neutral complex 1 occurred easily through the reaction of (RTe) 2 with mesTel (mes = 2,4,6-trimethylphenyl), which proved the ability of mesTel to act as a selective oxidation reagent. In the cationic species [R 2 TeTeR 2 ] 2+ as well in the counterion [Te 4 I 14 ] 2― of compound 2, tellurium occurs in the rare oxidation state 3+.
- Published
- 2009
50. Commentary to 'Original Koyanagi urethroplasty versus modified Hayashi technique: outcome in 57 patients'
- Author
-
G. Manzoni
- Subjects
Male ,medicine.medical_specialty ,Hypospadias ,Urologic Surgical Procedures, Male ,business.industry ,Urology ,Urethroplasty ,medicine.medical_treatment ,Outcome (game theory) ,Surgery ,Text mining ,Pediatrics, Perinatology and Child Health ,Medicine ,Humans ,business - Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.